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ABSTRACT 
 
Calcium plays an important role in the physiology of the cell, impinging upon a 
multitude of cellular events ranging from fertilization to cell proliferation and even 
cellular death (Berridge et al., 2000).  Therefore, intracellular calcium storage and 
regulated release is an important and physiologically relevant topic to address.  One 
mechanism by which calcium is mobilized from intracellular stores is via the activation 
of inositol 1,4,5-trisphosphate receptors (InsP3Rs) by the second messenger, inositol 
1,4,5-trisphosphate (InsP3).  InsP3 is produced when one of many neurotransmitters, 
hormones, or growth factors bind to G protein-coupled receptors on the plasma 
membrane, causing activation of phospholipase C.  Phospholipase C hydrolyzes 
phosphotidylinositol 4,5-bisphosphate into InsP3 and diacylglycerol, thus allowing InsP3 
to diffuse through the cytoplasm to bind to its receptor (Mignery et al., 1992).  InsP3Rs 
have a broad tissue and cellular distribution, with the receptor most commonly localized 
to the endoplasmic reticulum (ER) membrane.  InsP3Rs can be of three isoforms (type 1-
3), and are structurally very similar to each other.  Activation of InsP3Rs leads to release 
of calcium into the cytoplasm of the cell, where it can activate a multitude of signal 
transduction cascades and a variety of local and global cellular events.   
One such enzyme activated by a rise in intracellular [Ca2+] is Ca2+/calmodulin-
dependent protein kinase II (CaMKII).  CaMKII is a multifunctional Serine/Threonine 
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protein kinase involved in many signaling pathways in various cell types (reviewed in 
Maier and Bers, 2002).  The enzyme is composed of homomultimers or heteromultimers 
of 6-12 subunits, with the subunit isoforms being derived from a family of four closely 
related genes (α, β, δ, γ) (Hudmon et al., 2005).  All isoforms contain an amino-terminal 
catalytic domain where ATP binds, a central regulatory domain containing an auto-
inhibitory and calmodulin binding sites, and a carboxyl-terminal association domain.  
The δ and γ isoforms of CaMKII are the predominant isoforms found in the heart where 
they have been implicated in regulating cardiac gene expression.  Recent results from our 
lab have shown that the predominant InsP3R isoform in the heart, the InsP3R2, is 
primarily targeted to the nuclear envelope in ventricular myocytes.  Here it forms a 
macromolecular complex with the nuclear-localized cardiac isoform of CaMKII, 
CaMKIIδB (Bare et al., 2005).  Upon stimulation of InsP3 production, Ca2+ released 
through the InsP3R2 activates CaMKIIδB, allowing it to act on downstream targets, such 
as histone deacetylases 4 & 5 (HDAC4 & HDAC5) (Wu et al., 2006; Little et al., 2007).  
The results of this study and others (Zhu et al., 1996; Matifat et al., 2001; Wu et al., 
2006) suggest that the activity of InsP3Rs can be inhibited by CaMKII-mediated 
phosphorylation.  Furthermore, the N-terminal 1078 amino acids of the InsP3R2 have 
been shown to interact with, as well as be phosphorylated by CaMKII (Bare et al., 2005).  
However, it has not yet been established what amino acid(s) of InsP3Rs is/are 
phosphorylated. 
In this study, I use exogenously expressed fragments of the InsP3R2 and site-
directed mutagenesis to show that CaMKII can phosphorylate the InsP3R2 at Serine-150 
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and determine that phosphorylation of this residue is responsible for modulation of 
channel activity.  Non-phosphorylatable (S150A) and phospho-mimetic (S150E) 
mutations were constructed in the full-length InsP3R2, expressed in COS cells and 
studied in planar lipid bilayers.  Upon treatment with CaMKII, the non-phosphorylatable 
channel showed no decrease in activity. Conversely, the phosphomimetic channel 
displayed a very low Po under normal recording conditions in the absence of CaMKII (2 
μM InsP3 and 250 nM [Ca2+]FREE), thus mimicking a channel that has been 
phosphorylated by CaMKII. The results of this study show for the first time that Serine-
150 of the InsP3R2 is phosphorylated by CaMKII and results in a decrease in the 
channel’s open probability.  My hypothesis for the mechanism of the regulation of the 
InsP3R2 is that phosphorylation either alters the affinity for InsP3 at the ligand binding 
site and/or perturbs the intramolecular interactions necessary for proper ligand-induced 
gating, and this hypothesis is currently being tested. 
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CHAPTER ONE 
REVIEW OF RELEVANT LITERATURE 
 
A. INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR 
 
1. InsP3R Identification and Structure 
Inositol 1,4,5-trisphosphate receptors (InsP3Rs) are a family of highly conserved 
intracellular Ca2+ release channels, with each channel being a tetramer of four ~313 kDa 
subunits (reviewed in Bezprozvanny, 2005; Berridge, 2009).  This protein was first 
purified from rat cerebellum and determined to have a high affinity and specificity for 
inositol 1,4,5-trisphosphate (InsP3) (Kd ~100nM) when compared to other inositol 
phosphates (Worley et al., 1987; Supattapone et al., 1988).  The type 1 inositol 1,4,5-
trisphosphate receptor was cloned from mouse cerebellum and described by two groups 
simultaneously (Furuichi et al., 1989; Mignery et al., 1989), while functional studies 
showed that the membrane fraction of cells overexpressing the recombinant protein had 
enhanced InsP3 binding and InsP3-induced Ca2+ release capabilities (Miyawaki et al., 
1990).  The ligand InsP3 is produced when one of many neurotransmitters, hormones, or 
growth factors bind G protein-coupled receptors on the plasma membrane, causing 
activation of phospholipase C (PLC).  PLC hydrolyzes phosphotidylinositol 4,5-
 2
bisphosphate into InsP3 and diacylglycerol.  Diacylglycerol modulates protein kinase C 
activity, and InsP3 can diffuse through the cytoplasm to bind to its receptor (Mignery et 
al., 1992).  This pathway is commonly referred to as the PLC-InsP3 pathway.  For 
example, endothelin-1 (ET-1) is a physiological hypertrophic agonist that activates 
plasma membrane G protein-coupled receptors, producing the soluble second messenger 
InsP3 (Mignery et al., 1990).  InsP3 diffuses through the cytoplasm to activate InsP3R 
isoforms found in the cell and also has been shown to diffuse into the nucleus (Remus et 
al., 2006). 
InsP3Rs can be of three isoforms (type 1-3), and are structurally very similar to 
each other (Mignery et al., 1992).  The three isoforms of the InsP3R are encoded by three 
separate genes (Furuichi et al., 1989; Mignery et al., 1989), and each isoform of the 
InsP3R is encoded by a ~10kb RNA sequence leading to an approximately 2700-2800 
amino acid protein.  This protein along with three other monomers forms the functional 
InsP3R channel which is a tetramer of four subunits (Nakagawa et al., 1991; Sudhof et 
al., 1991; Blondel et al., 1993).  InsP3Rs have a broad tissue and cellular distribution, 
with the receptor most commonly localized to the endoplasmic reticulum (ER) 
membrane.  Often, multiple isoforms are expressed within a single cell allowing for 
isoform specific signaling and redundancy of function.   
A three-domain model for InsP3Rs has been proposed based on mutagenesis 
studies of the receptor (Figure 1).  The receptor is divided into an amino-terminal ligand-
binding domain, a central coupling or modulatory domain, and a carboxyl-terminal Ca2+ 
channel domain (Mignery et al., 1990).  The localization of InsP3 binding to the NH2-
terminus was established using recombinant, truncated proteins containing larger and  
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Figure 1: Three-domain model of InsP3R.   
 
The model shows that the InsP3R contains an N-terminal ligand binding domain which 
is comprised of an inhibitory region (in red) and the InsP3 binding core, a C-terminal 
channel domain containing six transmembrane regions, and an intervening ~1400 
amino acid modulatory region which couples ligand binding to channel gating and 
contains many sites for modulation of this interaction. When compared to the type 1 
InsP3R isoform, the type 2 and type 3 InsP3Rs are 69 and 64% identical, respectively, 
and the greatest divergence occurs in the Coupling/Modulatory region. 
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larger portions of the NH2-terminus (Mignery et al., 1990; Mignery and Sudhof, 1990).  
These and other studies determined that a truncated portion of the type 1 receptor 
containing the first 586 residues had the same InsP3 affinity and selectivity as the 
endogenous, full length type 1 receptor (Newton et al., 1994).  Additional observations 
from deletion mutagenesis studies of this region of the receptor showed that removal of  
the first 225 residues increased this mutant construct’s affinity for InsP3 10-100 fold in 
comparison to the endogenous receptor.  However, InsP3Rs lacking this region did not 
form functional channel units (Yoshikawa et al., 1996).  Thus, the region encompassing 
the amino acids from 1-225 were determined to play a role in the prevention of InsP3 
binding and termed the “suppressor domain”, while the amino acids from 226-586 were 
considered the InsP3 “binding core”.  The crystal structures of the suppressor domain 
(SD) and InsP3 binding core (IBC) of the mouse type 1 receptor have been elucidated 
(Bosanac et al., 2002; Bosanac et al., 2005). The binding core can be broken into two 
distinct domains; a β-trefoil domain comprised of amino acids 225-436, and an α-helical 
domain comprised of amino acids 437-586.  InsP3 has been proposed to bind at the 
interface of the two, with basic residues from each contributing to binding and affinity.  
Specifically, phosphates 1 and 5 of the InsP3 molecule interact with residues in the α-
helical domain, while phosphate 4 interacts with the β-trefoil domain of the IBC 
(Bosanac et al., 2002).  The suppressor domain also contains a β-trefoil domain referred 
to as the “head”, with an intervening helix-loop-helix region forming the “arm”.  The 
suppressor domain may function to both modulate the binding core and control channel 
gating through potential intramolecular interactions, as recent studies have shown that the 
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N-terminal 340 amino acids to interact specifically with the S4-S5 linker region in the 
type 1 InsP3R (Schug and Joseph, 2006). 
The coupling/regulatory domain of the three InsP3R isoforms is the least 
conserved region, possibly attributing to differences in regulation between the various 
isoforms (Mignery et al., 1992).  This domain also contains ATP-binding sites, PKA 
phosphorylation sites, and a proposed Ca2+-sensing region on the type 1 receptor.  Type 2 
and type 3 receptors have 69% and 64% overall amino acid sequence identity, 
respectively, to the type 1 receptor.  The receptor subtypes exhibit differential affinities 
for InsP3, with the type 2 receptor having nearly three fold greater affinity when 
compared to type 1.  The type 3 receptor exhibits the lowest affinity for InsP3 (see Figure 
2A).   
The C-terminal region of the receptor is comprised of the channel-forming 
domain.  This domain is proposed to be comprised of six transmembrane helices and 
includes the pore forming region of the InsP3R that has been localized to the S5-S6 
linker.  Following this region, there is a short cytoplasmic tail at the extreme C-terminus 
of the InsP3R.  Helices 5 and 6 seem to be critical for forming the basic pore structure and 
selectivity filter of the InsP3R.  Deletion of trans-membrane regions (TMR) 1-4 leaves 
only TMR-5 and 6, which are still able to form channels with normal conductance and 
selectivity characteristics (Ramos-Franco et al., 1999).  Ligand binding to the N-terminal 
ligand binding domain is translated into gating of the InsP3R channel (Mignery and 
Sudhof, 1990), opening the channel pore and releasing Ca2+ from its intracellular stores 
as described above.  Targeting of the InsP3R1 to the endoplasmic reticulum membrane 
has been localized to transmembrane regions 1 and 2 of the receptor, however, any  
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Figure 2: Summary of InsP3- and Ca2+-dependence of the three InsP3R isoforms.  
 
(A) The type 2 receptor has the highest affinity for InsP3, with the type 1 at 
approximately 4 fold lower than that and the type 3 about at least 10 x lower than the 
others. These measurements were done at 250 nM cytosolic Ca2+. (B) The type 1 InsP3R 
exhibits a bell-shaped Ca2+ dependence, with highest channel activity at ~1 μM Ca2+. The 
type 2 and type 3 receptors show little inhibition of channel activity at higher [Ca2+]. Note 
that for (A) and (B) single channel data for the type 1, 2, and 3 InsP3R channels is from 
Ramos-Franco et al., 1998b (red and blue curves) and Hagar et al., 1998 and Hagar & 
Ehrlich, 2000 (black dashed curves). Open probability (Po) for [InsP3]-dependence of 
type 3 is scaled up 5.5 х so the indicated ratio of maximum Po for type 3 / type 1 is as 
reported by Ehrlich’s group (measured maximum Po was 0.08, from Hagar & Ehrlich, 
2000).  (Figure modified from Bers D.M., Excitation-Contraction Coupling and Cardiac 
Contractile Force, 2003) 
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combination of two tandem TMRs linked by their luminal loops are sufficient to ensure 
proper targeting to the ER membrane (Pantazaka and Taylor, 2009).  This allows the N-
terminal ligand-binding domain to fold in the cytosol into a functional unit before the 
protein is anchored in the ER membrane.  Important oligomerization determinants were 
also shown to reside in the TMRs 5 and 6 of the carboxy terminus, with possible 
contributions from the cytoplasmic tail region (Galvan et al., 1999; Galvan and Mignery, 
2002).   
The three dimensional structure of the tetrameric InsP3R1 isolated from rat 
cerebellum has been determined by electron cryomicroscopy and single-particle 
reconstruction. The protein structure has four-fold symmetry resembling a pinwheel with 
four blades connected by a central region, presumably comprised of the TMRs and the 
pore forming region of the channel.  A large cytoplasmic domain protrudes from the 
structure to form the blades of the pinwheel, and the IP3-binding core of each subunit has 
been localized to this region (Serysheva et al., 2003). 
 
2.  Function and Regulation 
  In all tissues, InsP3Rs can be regulated by a variety of intracellular molecules 
such as protein kinases, numerous proteinaceous binding partners (reviewed in 
Bezprozvanny, 2005), and also by intracellular ions such as K+ (Marchenko et al., 2005), 
Ba2+, Mg2+ (Striggow and Ehrlich, 1996), and Ca2+ (Mignery et al., 1992; Perez et al., 
1997; Ramos-Franco et al., 2000).  Together, Ca2+ and InsP3 act to regulate InsP3R 
channel activity.  Reports of spontaneous InsP3R activity of very low Po have been shown 
(Ramos-Franco et al., 1998a and 1998b); however, both InsP3 and Ca2+ must be present 
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on the cytoplasmic side of the channel protein to activate it to appreciable levels.  A 
calcium sensor intrinsic to the InsP3R1 has been identified based on sequence alignment 
with the calcium sensing region of the RyR (Miyakawa et al., 2001).  It was shown that 
glutamate 2100 (E2100) of the rat InsP3R1 is a key residue involved in Ca2+-sensing of 
the channel.  Mutagenesis of this residue to aspartate, another acidic amino acid, resulted 
in a 10-fold decrease in the Ca2+-sensitivity of the receptor without affecting other 
properties of the channel.  Furthermore, substitution of glutamate 2100 by non-acidic 
residues (alanine & glutamine) decreased the Ca2+-sensitivity below the range of 
detection in this study (Miyakawa et al., 2001).  These data suggest E2100 is a critical 
residue in conferring Ca2+-sensitivity to the channel, however, this does not exclude other 
potential Ca2+-sensors from being part of this or other regions of the InsP3R because they 
may even be contained in other proteins associated with the receptor. 
Regulation of InsP3Rs by Ca2+ and InsP3 is very complex, with the open 
probability of the channel being dependent on both the intracellular [Ca2+] ([Ca2+]i) and 
the [InsP3].  Previous work has shown that the InsP3R isoforms exhibit varying 
sensitivities to regulation by [Ca2+]i (Ramos-Franco et al., 1998b; see Figure 2B).  In 
general for the InsP3R1, a small rise in cytoplasmic [Ca2+] serves to activate the channel 
and increase Po, while a higher cytoplasmic [Ca2+] inhibits channel activity.  Due to the 
interplay of Ca2+ and InsP3 on channel gating, a range of open probabilities can be 
observed when either Ca2+ or InsP3 is held constant and the other varied.  When examing 
cytoplasmic Ca2+-sensitivities of single InsP3R1 and InsP3R2 at a fixed [InsP3] (1 µM), it 
was shown that the Ca2+ regulation of type 1 and type 2 channels are very different.  The 
Ca2+-dependence of the InsP3R1 channel was bell-shaped, with maximum channel 
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activity at 1 µM Ca2+.  The InsP3R2 Ca2+-dependence, however, had a sigmoidal shape.  
Channels were active at relatively low [Ca2+] (~25 nM) and maintained activity over a 
broad range of Ca2+ concentrations (Ramos-Franco et al., 1998b).  The InsP3R3 channel 
Ca2+-dependence has been reported to be similar to that of the type 2 channel.  At a 
constant [InsP3], the channel activates at relatively low [Ca2+] and slowly reaches a 
maximal Po over a large range of Ca2+ concentrations, reaching a plateau at ~10 µM Ca2+. 
Like the type 2 channel, no Ca2+-feedback inhibition is observed (Hagar et al., 1998).   
The unique Ca2+- and InsP3-sensitivities of the three types of InsP3R may have 
physiological relevance in mediating different types of intracellular Ca2+ signals 
depending on which isoforms are expressed in a given tissue.  For example, the bell-
shaped Ca2+-dependence of the type 1 channel makes it ideal for mediating small, 
transient and oscillatory Ca2+ signals since Ca2+ can feedback and turn off the channel.  
Type 2 InsP3R-mediated signals have a sigmoidal Ca2+-dependence meaning termination 
of this signal is not intrinsically controlled by a Ca2+-dependent inactivation mechanism.  
Of significance in cardiac tissues where type 2 receptors are present, this sigmodial Ca2+-
dependence makes the InsP3R2 resistant to the RyR-mediated Ca2+ signals driving the 
cardiac contractile cycle and allows InsP3-dependent intracellular signaling cascades to 
operate independent of the global Ca2+ fluxes associated with contraction.  Termination 
of the type 2 response will occur upon depletion of the Ca2+ store, removal of the InsP3 
signal, or regulation through a modulatory protein or factor; whereas the type 1 receptor 
would be inhibited by the global Ca2+-fluxes of the contractile cycle.  The type 3 InsP3R, 
like the type 2 receptor, shows a lack of negative feedback from cytoplasmic Ca2+.  This 
allows the receptor to stay open in the presence of high [Ca2+] and initiate a rapid and 
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almost total release of Ca2+ from intracellular stores as long as InsP3 is present (Hagar et 
al., 1998; O’Neill et al., 2002; Hagar and Ehrlich, 2000).  This property of the type 3 
receptor makes it more suited to signal initiation rather than signal regeneration like the 
type 1 receptor, and this function has been shown in certain cell types (Nathanson et al., 
1994).  Thus, expression of multiple InsP3R isoforms in the same cells can produce 
complex patterns of Ca2+-signaling depending on the type and amount of each isoform 
present.  
Although not necessary for channel gating, the nucleotide adenosine-5’-
triphosphate (ATP) can also positively modulate InsP3Rs (Meyer et al., 1988; Smith et 
al., 1985; Taylor and Putney, 1985).  Like Ca2+ and InsP3, the ATP-dependent 
potentiation of endogenous and recombinant InsP3R channels is both complex and 
isoform dependent (Mak et al., 1999; Mak et al., 2001).  ATP can exist in the cell in two 
forms. One is the “free” form which is ATP not bound to any ions, and the other is the 
“bound” form which is ATP bound typically to Mg2+.  It was found for the type 1 InsP3R 
that free ATP concentrations ([ATP]FREE) in the cytoplasm could increase the channel’s 
Po.  The mechanism of this potentiation was found to be through the enhancement of the 
channel’s sensitivity to Ca2+ activation; however, the [ATP]FREE had no effect on the 
maximal Po observed for the channel (Mak et al., 1999; Mak et al., 2001).  Likewise, the 
InsP3R3 showed enhanced sensitivity to Ca2+ activation with increasing [ATP]FREE, while 
no effect on the max Po was reported (Mak et al., 1999).  The effect of [ATP]FREE on the 
InsP3R2 has not been reported.   
In addition to regulating InsP3R function directly, ATP has been postulated to 
indirectly regulate the InsP3R via kinases.  ATP is hydrolyzed by protein kinases for use 
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in phosphorylation of target proteins.  It was shown that specifically the glycolytically 
generated ATP fueled the CaMKII-dependent phosphorylation of the InsP3R in 
endothelial cells, and inhibition of glycolysis decreased the ATP available to the kinase 
and reduced the inhibitory effect of the kinase on the InsP3R (Aromolaran et al., 2007).  
Thus the source of the free ATP in the environment of the InsP3R, either from 
mitochondrial respiration or cytoplasmic glycolysis, is important in the differential direct 
and indirect regulation of the InsP3R by ATP. 
Based on sequence homology, three putative ATP binding sites were identified in 
InsP3Rs as glycine-rich motifs with the sequence G-x-G-x-x-G (Wierenga and Hol, 
1983;Maes et al., 1999).  Of these three sites, only two of them have been biochemically 
proven to bind ATP in the InsP3R (Maes et al., 1999; Maes et al., 2001).  The two sites 
are referred to as the ATPA and ATPB sites.  The ATPA site is found only in the type 1 
InsP3R and is located at residues 1773-1778.  The ATPB site, residues 2016-2021 of the 
InsP3R1, is found in all three isoforms (Maes et al., 1999).  Site-specific binding of ATP 
to either the A or B site has not yet been correlated with functional effects of ATP on the 
InsP3R channel. 
Modulation of the channel’s sensitivity to Ca2+ activation by [ATP]FREE has been 
postulated to have important physiological consequences.  The apparent affinity of the 
two proven ATP binding sites (A & B) of the InsP3R1 and InsP3R3 has been shown to be 
~300 µM, which correlates with the cytoplasmic [ATP]FREE of ~400-600 µM (Mak et al., 
1999; Mak et al., 2001).  This allows the activity of InsP3Rs to be adjusted to the 
metabolic state of the cell.  The proximity of the ER to the mitochondria has been well-
documented, specifically in regions of high InsP3R protein density and Ca2+ release (Otsu 
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et al., 1990; Satoh et al., 1990; Rizzuto et al., 1998).  This location allows the 
mitochondria to sense the Ca2+ released from the InsP3Rs (Babcock and Hille, 1998; 
Csordás et al., 1999) and the InsP3Rs to sense the free ATP released by the mitochondria 
(Klingenberg, 1980).  This two way communication between the ER and mitochondria 
could be significant in regulated signaling microdomains and potentially play a role in 
apoptosis. 
A final agonist of InsP3Rs worth mentioning is Adenophostin A (AdA).  AdA, a 
fungal glyconucleotide metabolite, activates InsP3Rs by binding to the InsP3-binding site 
(Takahashi et al., 1994; Glouchankova et al., 2000).  In fact, AdA binds with a much 
higher affinity than InsP3 and is much more efficacious at stimulating Ca2+ release 
(Glouchankova et al., 2000; Bird et al., 1999).  Of significance experimentally, AdA is 
metabolically stable, whereas InsP3 is susceptible to conversion to other inositol 
polyphosphates by kinases and phosphatases (Adkins et al., 2000b).  Furthermore, the use 
of AdA and also many synthetic analogs of InsP3 are invaluable tools in studying InsP3 
binding and the gating mechanisms of the InsP3Rs (Rossi et al., 2009; Borissow et al., 
2005; Correa et al., 2001). 
The activation of InsP3 receptors results in a release of Ca2+ from intracellular 
stores, and they therefore play an important role in the regulation of intracellular [Ca2+].  
The sarcoplasmic/endoplasmic reticulum (SR/ER) is the primary Ca2+ storage organelle 
in most cell types.  The SR/ER membrane Ca2+-ATPases (SERCA) accumulate Ca2+ in 
the SR/ER lumen, with free [Ca2+] estimated to be between 100 and 700 µM (Palmer et 
al., 2004).  The low free [Ca2+] in the cytosol (50-100 nM) provides a steep chemical 
gradient for calcium to diffuse from ER stores into the cytoplasm when InsP3 binds to ER 
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membrane InsP3Rs.  Calcium in the cytoplasm moves by passive diffusion, and its rate is 
reduced by calcium binding proteins present there.  The result is the formation of calcium 
microdomains due to the steep concentration gradients that form and dissipate around the 
mouth of an InsP3R channel.  Calcium concentrations at the exit of the pore can be 100 
µM or more, with a dramatic reduction of approximately 100-fold less as one moves even 
1-2 µm away from the pore (Naraghi and Neher, 1997; Rios and Stern, 1997; Neher, 
1998). 
Calcium release events from InsP3Rs can be grouped into three broad categories.  
First is the calcium blip, which is the elementary calcium release event from a single 
InsP3R channel (Parker et al., 1996).  The next level of release is the calcium puff, 
observed when a cluster of InsP3Rs become activated and open (Swillens et al., 1999).  
Finally, the calcium wave is the largest unit of calcium release events from InsP3Rs 
observed in cells.  The wave propagates via a cycle of calcium release, diffusion, and 
calcium-induced calcium release (CICR) between InsP3R channels (Bootman and 
Berridge, 1996; Cheng et al., 1996; Berridge, 1997; Callamaras et al., 1998).  Here the 
calcium released from a cluster of InsP3Rs diffuses to a nearby cluster of InsP3Rs and 
activates them, thus releasing calcium and beginning the cycle again.  Of course InsP3 
must also be present for the channels to activate, albeit at a concentration that is 
dependent on the isoform of InsP3R expressed and the amount of calcium sensed by the 
InsP3R protein.  The Ca2+ released can then regulate a multitude of cellular signaling 
cascades and even feedback to inhibit the activity of the type 1 InsP3R and terminate Ca2+ 
release.   
 14
The elementary calcium release events described above allow for highly localized 
signals due to the fact that Ca2+ in the local vicinity of the InsP3R pore is much higher 
than in the bulk cytosol.  Thus, it is no surprise that Ca2+ released locally via InsP3 
receptors has multiple consequences aside from potentially inducing CICR from 
neighboring Ca2+ release channels.  For example, it can stimulate the activation of key 
intracellular enzymes, one of which is Ca2+/calmodulin-dependent protein kinase II 
(CaMKII) (Wu et al., 2006).  Furthermore, an extremely elegant subcellular arrangement 
of InsP3R subtypes with their distinct properties and expression of calcium binding 
proteins within a given cell type allows those cells to have diverse spatial and temporal 
control over the InsP3-mediated calcium signals that can be utilized.  Along with 
localization and isoform expression levels, the distinct single channel properties of the 
InsP3Rs allow for this type of control of calcium release and termination.   
 
3. Properties of the InsP3R channel 
Based on site-directed mutagenesis (Boehning et al., 2001) and the results using 
the construct with the deletion of TMRs 1-4 described previously (page 5; Ramos-Franco 
et al., 1999), the pore of the InsP3R is proposed to be contained in TMR-5 and 6 and their 
intervening sequence.  Studies have shown the pore of the InsP3R to have relatively low 
energy barriers for divalent cation entry when compared to monovalent cation entry.  
Thus the InsP3R exhibits higher divalent cation permeabilities and stronger binding to the 
divalent cations once they are inside of the pore.  This results in observed divalent 
blocking of the channel (Mak and Foskett, 1998) and also causes decreased monovalent 
conductance when divalents are present.  Although the InsP3R is selective for divalents 
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over monovalents, it shows little selectivity between divalent cations including Ca2+, 
Mg2+, and Ba2+ (Mak and Foskett, 1998).  Despite the preference for divalents over 
monovalents, the InsP3R has shown higher conductances for monovalent cations 
implying that selectivity and conductance are distinct properties.  
 Ramos-Franco et al. (1998a and 1998b; 2000) studied the channel properties of 
native InsP3R1 and InsP3R2 purified from tissues and reconstituted into proteoliposomes.  
Theses two channels were found to each have very similar conductances for Ca2+ 
(InsP3R1 and InsP3R2 both approximately 70 pS) and Cs+ (InsP3R1 and InsP3R2 both 
approximately 280 pS), suggesting that different InsP3Rs have similar permeation 
properties.  Other groups have measured InsP3R channel conductances using InsP3R 
protein from various sources (purified from native tissue, overexpressed recombinant 
protein in mammalian and insect cells), lipid environments (native ER or 
proteoliposomes), and recording conditions (presence of divalents and monovalents).  
The clear result from these studies is that the InsP3R channel conducts monovalents better 
than divalents.  Another advantage to using the monovalent Cs+ as opposed to the 
divalent Ca2+ as the charge carrier is that this allows precise control of Ca2+ levels around 
the channel, thus removing any uncontrolled Ca2+ inhibition or activation from these 
measurements.  Furthermore, Cs+ blocks K+ channels that may be present in the 
preparation.  Current amplitude was found to be dependent on the driving force, with a 
linear I-V relationship for both Ca2+ and Cs+ over a range of membrane holding potentials 
from -70-+60 mV.  At 0 mV, a Cs+ current amplitude of ~5-8 pA was recorded (Ramos-
Franco et al., 1998b). 
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 Based on homology with RyR and K+ channels, a putative selectivity filter was 
determined to be part of the pore-forming S5-S6 linker region.  For the rat InsP3R1, the 
residues 2547GVGD2550 have been the focus of studies examining the selectivity filter of 
the InsP3R.  Mutating these residues individually to conserved or non-conserved 
mutations produced either altered selectivity or altered conductances.  Thus the InsP3R 
pore has distinct sites that control permeation and selectivity (Boehning et al., 2001; 
Schug et al., 2007).  The activation gate is also a feature of the InsP3R that is not well 
characterized.  Similar to the identification of the selectivity filter, much of what is 
predicted about the location and function of the activation gate of the InsP3R channel 
comes from comparisons and homology to K+ channels (Kuo et al., 2003; Long et al., 
2005).  It has been speculated that conformational changes from InsP3 binding are 
transduced to the activation gate, enabling ion flow through the pore.  It is possible the 
interaction between the N-terminus and S4-S5 linker (Schug and Joseph, 2006) provides 
the conduit for the binding of InsP3 to translate into the movement of the activation gate 
through conformational changes that allow ions to move through the pore.   
As stated above, the InsP3R is more permeable to divalent cations; however, it has 
a higher conductance for monovalent cations.  Therefore, it has been estimated that the 
actual Ca2+ current through an open InsP3R in the ER of a cell is approximately 0.1-0.2 
pA (Kettlun et al., 2003; reviewed in Foskett et al., 2007) due to the K+ and Mg2+ present 
in the cytoplasm.   
 
4. Phosphorylation of InsP3Rs by Protein Kinases 
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Along with InsP3 and Ca2+ signals, a third important facet to the regulation of 
InsP3Rs is phosphorylation.  Protein phosphorylation was first discovered in 1955 when it 
was observed that both ATP and a “converting enzyme” (now known to be a kinase) 
were required to convert a protein into a phospho-protein (Fischer and Krebs, 1955).  
Since then, cycles of phosphorylation by protein kinases and de-phosphorylation by 
protein phosphatases have been found to be an essential signaling mechanism present in 
all living organisms.  Protein kinases mainly phosphorylate their substrates on one of 
three hydroxyl-containing amino acids.  These amino acids are Serine, Threonine, and 
Tyrosine, with Serine/Threonine phosphorylation accounting for 98.2% of 
phosphorylation sites present in the human proteome (Olsen et al., 2006).  Multiple 
kinases, including cAMP-dependent protein kinase (PKA), protein kinase B (PKB/Akt), 
protein kinase C (PKC), and Ca2+-calmodulin-dependent protein kinase II (CaMKII) have 
been shown to phosphorylate InsP3R proteins.  Furthermore, purified InsP3R1 has been 
shown to be phosphorylated by PKA and PKC on serine residues as determined by 
electrophoresis of phosphorylated amino acids after acid hydrolysis of phosphopeptides 
(Ferris et al., 1991). 
The InsP3R1 contains two consensus PKA sequences (R-R-x-S/T) at Ser-1589 
and Ser-1755; however, these sites are not conserved in either the type 2 or type 3 
isoforms.  PKA phosphorylation of the type 1 InsP3R has been the most fully 
characterized of all the isoform-specific phosphorylation events.  Initially, it appeared 
that PKA phosphorylation of the InsP3R resulted in an increase in the affinity of InsP3R 
for InsP3 because less InsP3 was needed to produce increases in the channel’s Po.  
However, in an in-depth single channel characterization of the InsP3R1 that has been 
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phosphorylated by PKA, it was found the phosphorylation of the channel results in an 
increase in the Po of the channel by destabilizing a long-lived closed state of the channel 
to facilitate bursting activity (Wagner et al., 2008).  It is also of note to recognize that the 
InsP3R1 forms a complex with PKA and distinct protein phosphatases.  Pull-down 
experiments resulted in precipitation of the InsP3R1 along with PKA, protein phosphatase 
1 (PP1), and protein phosphatase 2A (PP2A), thus showing a macromolecular signaling 
complex exists in the rat brain (DeSouza et al., 2002).  PKA has been shown to 
phosphorylate the mouse InsP3R2 at Serine 937.  This phosphorylation results in an 
increase in the Po of the channel, but the mechanism behind this increase has not yet been 
elucidated (Betzenhauser et al., 2009).  
PKB/Akt is a serine/threonine protein kinase that phosphorylates a number of key 
substrates to promote cell survival and proliferation.  It can phosphorylate the InsP3R1 on 
Serine 2681, causing a decrease in InsP3-induced calcium release.  Physiologically, this 
pathway is proposed to be important to cell survival and the apoptotic pathway.  Under 
normal growth conditions, PKB/Akt maintains a basal level of InsP3R1 phosphorylation.  
In the absence of growth factors, decreased PKB/Akt activity results in larger calcium 
release from unphosphorylated InsP3Rs.  It is hypothesized that this calcium can be 
sensed by closely localized mitochondria causing permeability transition and apoptosis.  
In the context of cancer where there is increased PKB/Akt activity, this “protects” the 
cancer cell from apoptotic stimuli allowing the cell to survive and proliferate (Szado et 
al., 2008).  No PKB/Akt phosphorylate of the type 2 or 3 InsP3R has been reported. 
PKC has been shown to increase InsP3-induced Ca2+ release from tissues such as 
cerebellum, which express predominantly the type 1 isoform (Matter et al., 1993; Poirier 
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et al., 2001).  The InsP3R2 has recently been shown to be a substrate for PKC; however, 
it was found to decrease InsP3-induced Ca2+ release in cells as a result of a diminished 
apparent affinity of the receptor for InsP3 (Arguin et al., 2007)).  This study was done in a 
cell line known as AR4-2J that expresses predominantly the type 2 isoform.  This 
provides a negative feedback mechanism for the type 2 InsP3R whereby calcium released 
by the receptor can activate PKC which phosphorylates and inhibits InsP3R2 activity. 
CaMKII can phosphorylate the InsP3R1 on a serine residue (Ferris et al., 1991), 
and this has been shown to result in a decrease in InsP3-dependent Ca2+ release in HeLa 
cells (Zhu et al., 1996) and Xenopus oocytes (Matifat et al., 2001).  In calf pulmonary 
artery endothelial (CPAE) cells, CaMKII was found to exert a profound inhibition of 
Ca2+ release from ER stores (Aromolaran and Blatter, 2005; Aromolaran et al., 2007).  
These cells were reported to express predominantly type 2 InsP3Rs, and the inhibition of 
Ca2+ release was postulated to be through CaMKII-depedent phosphorylation of the 
InsP3R (Aromoloran et al., 2007).  Furthermore, it has been shown that CaMKII can 
associate with and phosphorylate the InsP3R2 in cardiac ventricular myocytes (Bare et 
al., 2005).  The region of phosphorylation was determined to be in the first 1078 amino 
acids and resulted in a decrease in channel open probability (Bare et al., 2005); however, 
the specific site still remains unknown.  CaMKII has been shown to preferentially 
phosphorylate the amino acid motif R-x-x-S/T, with other amino acids upstream and 
downstream of this motif participating in the affinity of the kinase for this site (White et 
al., 1998).  Sequence search for the minimal consensus CaMKII phosphorylation site of 
amino acids R-x-x-S/T (White et al., 1998) or the RyR2 CaMKII phosphorylation site S-
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x-D motif (Wehrens et al., 2004) in the type-2 receptor reveals 17 potential 
phosphorylation sites. 
 
 5. InsP3Rs in the heart 
The expression of the InsP3R has been shown to be most abundant in the early 
embryonic development stages, with levels decreasing with progression to adulthood 
(Rosenblit et al., 1999).  Despite this, the InsP3R has been shown to have multiple roles in 
the adult heart including modulation of excitation-contraction coupling (ECC), part of the 
excitation-transcription coupling pathway (ETC), and a contributor to generation of 
arrhythmias in both atria (Zima and Blatter, 2004) and ventricles (Proven et al., 2006) of 
different species.  In cardiac myocytes, a number of neurohumoral agents such as ET-1, 
phenylephrine, and acetylcholine can act via cell-surface receptors to activate the 
pathway leading to production of InsP3 and activation of InsP3Rs.  The type 2 InsP3R is 
expressed in multiple tissues and has been shown to be the predominant isoform in 
cardiac myocytes (Perez et al., 1997).  In addition, the type 2 and type 3 receptors were 
found to be expressed at higher levels in the atria as compared to ventricles in rabbit 
myocytes (Domeier et al., 2007).  Although it is the predominant InsP3R isoform, a close 
relative of the InsP3R known as the ryanodine receptor (RyR) is the major Ca2+ release 
channel of the sarcoplasmic reticulum (SR) in excitation-contraction coupling in cardiac 
myocytes.  In atrial tissues, more functional InsP3Rs may be expressed compared to 
ventricular myocytes, and populations of them have been shown to co-localize with RyRs 
in the subsarcolemmal space (Mackenzie et al., 2002).  Here, InsP3-dependent Ca2+ 
release can enhance calcium-induced calcium release (CICR) from neighboring RyRs, 
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thus causing positive inotropy in the heart (Zima and Blatter, 2004).  Recent data from 
Domeier et al. (2007) has also shown that InsP3-dependent Ca2+ release from InsP3Rs 
presumably located on the SR of the cell has an effect on excitation-contraction coupling 
in rabbit ventricular myocytes.  Activation of InsP3R2 resulted in positive inotropic 
effects due to facilitation of Ca2+ release from RyR clusters on the SR providing a role for 
InsP3Rs to modulate E-C coupling in ventricular myocytes.  However, this increase in 
Ca2+ transients can also lead to arrhythmias in atrial and also ventricular myocytes.  
InsP3Rs have been shown to play a role in the modulation of ECC and also in the 
generation of arrhythmias.  ET-1 increased diastolic [Ca2+]i, increased the amplitude of 
electrically evoked transients, and caused spontaneous transients in cat atrial myocytes 
(Zima and Blatter, 2004).  In support of these data, Li et al. (2005) showed that in 
response to ET-1 application InsP3R2-KO mouse atrial myocytes failed to increase 
diastolic [Ca2+]i and to have a positive inotropic effect.  In addition, ET-1 also failed to 
elicit spontaneous Ca2+ release events typically seen with ET-1 application. 
Aside from increasing cytoplasmic Ca2+ transients, ET-1 was also shown to 
increase Ca2+ transients in the nucleus.  In fact, the increase in nuclear Ca2+ transients was 
greater than the increase in cytoplasmic transients.  Furthermore, ET-1 at low 
concentrations caused selective increases in nuclear Ca2+ transients through InsP3Rs 
(Kockskämper et al., 2008).  A study using isolated nuclei from whole heart showed that 
InsP3Rs release Ca2+ into the nucleoplasm when stimulated with InsP3.  InsP3-induced 
calcium release (IICR) was observed at both the outer and inner face of the nuclei, with 
nuclear [Ca2+] rising to levels higher than those observed in the area immediately 
surrounding the outer membrane of the nucleus (Zima et al., 2007).  The nuclear 
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envelope was also loaded with the low affinity Ca2+ dye fluo-5N to measure nuclear 
envelope [Ca2+] directly, and InsP3 application reduced the Ca2+ stored in the nuclear 
envelope.  The presence of InsP3Rs on the nuclear envelope and its function as a 
releasable calcium store are not surprising given the fact that the sarcoplasmic reticulum 
and the nuclear envelope and are one highly interconnected Ca2+ store throughout the 
cardiac myocyte (Wu and Bers, 2006). These results also suggests that possibly a higher 
density of the nuclear InsP3Rs are located on the inner nuclear membrane for Ca2+ release 
into the nucleoplasm where it can activate nuclear localized CaMKII resulting in local 
nuclear Ca2+ signaling (Zima et al., 2007).   
To go along with the presence of InsP3Rs on the inner and outer nuclear envelope, 
it was shown that InsP3 can diffuse long distances through the cytosol and even into the 
nucleus.  Remus et al. (2006) used the FRET (fluorescence resonance energy transfer)-
based InsP3 biosensor, FIRE1 (fluorescent InsP3-responsive element), to follow InsP3 
produced at the plasma membrane in cells treated with endothelin-1.  With this biosensor, 
they were able to show that InsP3 diffused through the cytosol of ventricular myocytes 
and into the nucleus via nuclear pore complexes.  InsP3 levels rose more rapidly and to a 
higher level in the cytosol compared to the nucleus, and the experiment convincingly 
demonstrates the diffusional capabilities of InsP3 intracellularly.  They had also shown 
that neurohumoral activation in ventricular myocytes resulted in rapid rises of [InsP3] in 
the cytoplasm and nucleus. 
The InsP3R2 is part of a nuclear signal transduction cascade involving CaMKII 
and HDAC5 phosphorylation and its resulting nuclear export.  This pathway seems to be 
isolated from the beat-to-beat global fluctuations in [Ca2+]i, creating an elegant system 
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that is dependent on very local control of [Ca2+] around the pore of the InsP3Rs.  The 
hypothesis is that InsP3 can activate nuclear envelope InsP3Rs, releasing Ca2+ into the 
nucleoplasm with very high concentrations of Ca2+ immediately adjacent to the mouth of 
the InsP3R activating CaMKII, which can phosphorylate HDAC5 and cause its 
translocation out of the nucleus.  The chronic, sustained stimulation with InsP3-producing 
agonists causes de-repression of MEF2-dependent transcription allowing altered gene  
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Figure 3: Immunofluorescence staining of heart failure and wild-type rabbit 
myoctes 
 
Isolated rabbit myocytes were immunostained with T2NH antibody against the InsP3R2.  
Myocytes were isolated from both healthy (WT) and heart failure (HF) New Zealand 
white rabbits (supplied by S.M. Pogwidz).  Heart failure in the HF rabbits was induced 
by combined aortic insuffiency and stenosis (Pogwidz, 1995).  Both heart failure and 
WT myocytes show fluorescent signal around the myocyte nuclei (A & B); however, the 
heart failure myocytes (A) show enhanced nuclear envelope staining for the InsP3R2 
when compared with the faint signal seen in WT myocytes (B).  The myocytes were 
incubated with the same dilution of primary and secondary antibodies, and the images 
were aquired at similar exposure intervals. 
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expression that leads to hypertrophy and heart failure in a process that has been termed 
excitation-transcription coupling (ETC) (Wu et al., 2006). 
InsP3Rs have also been implicated, as previously mentioned, in pathological 
conditions of the heart.  Specifically, their role in development of hypertrophy, heart 
failure (HF), and atrial fibrillation (AF) has been studied by multiple groups.  It has been 
shown that InsP3Rs are upregulated in the atrial myocytes of human patients with AF 
(Yamada et al., 2001).  Presumably, the increased expression of InsP3Rs along with the 
increased levels of InsP3-producing agonists ET-1 and also angiotensin II found in 
subjects with AF, lead to the initiation and progression of atrial fibrillation.  The role of 
InsP3Rs in hypertrophy come from studies showing that in pressure-overload induced 
hypertrophy PLC activity was increased leading to increased levels of InsP3 (Kawaguchi 
et al., 1993), and in volume-overload induced hypertrophy the levels and activities of 
PLC1 and PLC3 were increased again leading to increased levels of InsP3 (Dent et al., 
2004).  In heart failure, the levels of expression of the InsP3R2 have been shown to be 
increased (Go et al., 1995; JT Maxwell & GA Mignery, Figure 3).  Specifically, 
CaMKIIδ contributes to the altered expression levels of multiple proteins including the 
upregulation of InsP3R2 in the ventricles during the development of pressure overload-
induced HF (Ling et al., 2009).  Thus InsP3Rs and their ligand InsP3 have roles in the 
initiation and progression of severe cardiac dysfunctions.   
 
6. Interacting Proteins 
The InsP3R has been shown to interact with a multitude of proteins and factors, 
some of which have been described already; however, there are a few more that are 
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relevant to this study that warrant discussion.  One of those proteins is Calmodulin 
(CaM), which is a Ca2+-binding protein shown to be a co-factor of many ion channels 
(Saimi and Kung, 2002).  The first CaM binding site on the InsP3R1 was found to be 
Ca2+-dependent and was identified as encompassing residues 1564-1585 (Maeda et al., 
1991).  A second CaM site that bound both CaM and apoCaM equally was found in the 
N-terminus suppressor domain, with amino acids 49-81 and 106-128 involved in the 
interaction (Adkins et al., 2000a; Sienaert et al., 2002).  The exact function that CaM has 
in complex with the InsP3R has been studied, but a consensus is yet to be reached.  Also, 
CaM binding to the other isoforms has not been demonstrated; however, the regions of 
interaction with the InsP3R1 are conserved in both the InsP3R2 and InsP3R3 proteins.  
Aside from potentially conferring Ca2+-activation or Ca2+-inhibition to the channel, it is 
possible that CaM is part of a larger macromolecular complex regulating other facets of 
InsP3R activity.  The location of the CaM binding site on the large cytoplasmic domain of 
the receptor in cell allows it to interact with many other cytoplasmic proteins and also 
positions it in a region where it can be activated by InsP3R2-mediated Ca2+ release. 
Two other proteins that bind to the N-terminus of the InsP3R are RACK1 and 
Homer.  RACK1 is an adaptor protein identified through a yeast two-hybrid screen to 
interact with two specific sites in the InsP3R at residues 90-110 and 580-600 (Patterson et 
al., 2004).  In addition to its function as an adaptor protein, RACK1 may serve to 
stabilize the InsP3-binding domain and increase the channel’s sensitivity to InsP3 
(Patterson et al., 2004).  The scaffolding protein Homer binds to a proline-rich region of 
the N-terminus of the InsP3R at residues 49-54 (Fagni et al., 2002).  Homer contains a 
coiled-coil region important for binding other Homer proteins and forming a multimeric 
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protein complex (Tu et al., 1998; Yuan et al., 2003).  A direct effect of Homer on the 
InsP3R has not been demonstrated.  As detailed here, the large cytoplasmic domain of the 
InsP3Rs comprised of the ligand-binding domain and the modulatory/coupling domain 
contains many sites of interaction and regulation by a variety of proteins and factors in 
addition to its reported intramolecular interaction with the C-terminus. 
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B. Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE II 
 
1.  Structure and Regulation 
CaMKII is a multifunctional Ser/Thr protein kinase.  The enzyme is composed of 
homomultimers or heteromultimers of 6-12 subunits, with the subunit isoforms being 
derived from a family of four closely related genes (α, β, δ, γ) (Hudmon and Schulman, 
2002).  All isoforms contain an amino-terminal catalytic domain where ATP binds, a 
central regulatory domain containing an auto-inhibitory and calmodulin binding sites, and 
a carboxyl-terminal association domain (Figure 4).  The association domain is 
responsible for oligomerization of CaMKII subunits.  Calmodulin (CaM) is a Ca2+-
binding protein that contains four EF hand motifs, each of which binds a Ca2+ ion 
(Braunewell and Gundelfinger, 1999).  CaM has a structure of two symmetrical domains 
linked by a central hinge region.  CaM cooperatively binds four Ca2+ ions then undergoes 
a conformational change that allows it to recognize and bind target proteins.  Thus Ca2+ 
regulates the activity of CaM through structural changes in the protein from the Ca2+-
bound form to the Ca2+-free form (apo-calmodulin).  The complex of Ca2+ and 
calmodulin binds to the regulatory domain of CaMKII, removing its hindrance on the 
active site.  The now open active site can bind to target substrates within the cell.  Half 
maximal activation of CaMKII occurs at [Ca2+]i of approximately 500-1000 nM.  This 
Ca2+-dependent activated state can then undergo an auto-phosphorylation event at 
Threonine-286 (Threonine-287 in some isoforms).  This would convert the enzyme to a 
Ca2+-independent state, allowing it to remain active after intracellular [Ca2+] has  
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Figure 4: CaMKII domains and oligomerization.  
 
The three main domains of the CaMKII monomer are indicated in the linear layout 
(top). Middle left shows that CaMKII forms homo- or heteromultimers (6-12 
monomers) in wheel-like structures (a second one may sit on top of the one shown, 
forming a double wheel). Lower, middle, and right panels show activation of CaMKII 
by Ca2+-CaM binding and subsequent autophosphorylation at Thr-286 (or Thr-287 in δB 
isoform). CaM binding is sufficient to activate CaMKII so the active site (ATP) can 
interact and phosphorylation target proteins, but autophosphorylation makes CaMKII 
active (20-80%) even after CaM dissociates. (Figure modified from Maier & Bers, 
2002). 
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decreased, such as during diastole.  This auto-phosphorylation has multiple effects on the 
enzyme and is not a prerequisite for kinase activity (Fukunaga et al., 1992).  First, it 
increases the affinity of the kinase for the calmodulin complex.  Autophosphorylation, 
and even high [Ca2+]i, can cause the affinity of CaMKII for CaM to increase ~700 fold, 
thus the kinase retains full activity as long as calmodulin is trapped by CaMKII.  Also, 
due to the position of the auto-phosphorylation site, addition of the phosphate to Thr-286 
is sufficient to remove autoinhibition and produce 20-80% kinase activity (reviewed in 
Maier and Bers, 2002).  The activity of CaMKII can be blocked with organic inhibitors 
KN-62 or KN-93, a non-phosphorylatable peptide inhibitor known as autocamtide-2 
related inhibitory peptide (AIP), and also with non-hydrolysable analogs of ATP 
(Hudmon et al., 2005).  Constitutively active CaMKII mutants have previously been 
made by point mutagenesis of Threonine-286 to Aspartate-286, which mimics 
autophosphorylation and allows the kinase to maintain activity in the absence of the 
Ca2+/calmodulin complex (Backs et al., 2006).  
 
 2.  Localization and Function 
It has been shown that CaMKII, due to its ability to sense changes in intracellular 
[Ca2+], plays a role in decoding the frequencies of Ca2+ oscillations.  Various cell types 
exhibit changes in intracellular [Ca2+] as a response to stimuli ranging from electrical to 
chemical.  A key pathway in changing intracellular [Ca2+] is the phosphoinositide 
cascade resulting in the production of InsP3 as an intracellular signaling molecule.  It has 
long been speculated that information may be encoded in the amplitude, frequency, and 
duration of these oscillations of intracellular [Ca2+] (Bootman and Berridge, 1996).  
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CaMKII has many intracellular phosphorylation targets and therefore would be well 
suited to connect changes in intracellular [Ca2+] to changes in cellular functions 
(DeKoninck and Schulman, 1998). It has been shown that CaMKII phosphorylation of 
membrane proteins requires that the enzyme be targeted and anchored to the membrane 
containing these substrates, whereas phosphorylation of cytosolic proteins does not 
require any CaMKII translocation (Tsui et al., 2004).  This allows CaMKII to be tightly 
regulated in a signaling microdomain comprised of a macromolecular complex of 
proteins including the kinase, its substrate(s), and protein phosphatases.  It has previously 
been shown in the brain, where CaMKII expression is high, that this CaMKII is involved 
in frequency dependent changes in synaptic transmission, such as long-term potentiation 
(LTP) and long-term depression (LTD) (Malinow et al., 1989).  Thus repetitive Ca2+ 
spikes may result in auto-phosphorylation of the enzyme and prolonged kinase activity.  
In fact, DeKoninck and Schulman (1998) have shown that this is the case, as the function 
of CaMKII as a frequency decoder of Ca2+ oscillations is critically dependent on the Ca2+ 
spikes producing auto-phosphorylation of the enzyme.  Above the threshold for kinase 
activation some subunits of the enzyme become auto-phosphorylated, and the response to 
low-frequency stimulation is increased.  Sub-maximal activation of the kinase by single 
Ca2+ spikes would not result in auto-phosphorylation, and the enzyme would remain 
dependent on Ca2+ for activity.  These features of the enzyme allow CaMKII to transition 
to persistently activated forms depending upon the frequency of Ca2+ oscillations.  In a 
study by Hudmon et al. (2005), a physical interaction of CaMKII with L-type Ca2+ 
channels was shown, and this interaction was proven to be critical for CaMKII’s role as 
an integrator of Ca2+ spikes involved in Ca2+-dependent facilitation (CDF) of voltage-
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gated Ca2+ channels.  This interaction of CaMKII and its substrate position the kinase to 
act as a specific frequency decoder of the calcium spikes.  Another key finding from this 
study is that CaMKII is not dependent on its interaction with the L-type Ca2+ channel to 
maintain activity.  Thus, it is possible that CaMKII can dissociate from the channel and 
maintain its kinase activity to act on other targets.  This study elegantly demonstrated that 
the interaction of CaMKII with the L-type Ca2+ channel allowed for the enzyme to act as 
a local sensor monitoring activity of the Ca2+ channel and as a kinase to regulate that 
activity.  
 
3. CaMKII in the heart 
The δ and γ isoforms of CaMKII are the predominant isoforms found in the heart 
(Hudmon et al., 2005).  The δ-isoform can be classified as CaMKIIδC, the cytosolic 
splice variant, or CaMKIIδB, which is the nuclear splice variant since it contains a nuclear 
localization signal (Kohlhaas et al., 2006).  These isoforms have been implicated in the 
modulation of excitation-contraction coupling (ECC) and in regulating gene expression in 
cardiac tissue (summarized in Maier and Bers, 2007).  It was found that phosphorylation 
by either the δB or δC isoform has distinct effects on Ca2+-handling proteins in the heart, 
however, both isoforms similarly regulated hypertrophic gene expression through HDAC 
phosphorylation (Zhang et al., 2007).  CaMKII plays a role in modulating ECC by direct 
phosphorylation of several key proteins involved in the regulation of Ca2+.  These 
proteins include the RyR (Witcher et al., 1991; Hain et al., 1995), phospholamban (PLB) 
(Davis et al., 1983; Simmerman et al., 1986) and L-type Ca2+ channels (see Maier and 
Bers, 2002; Hudmon et al., 2005).  Furthermore, endogenous CaMKIIδ was shown to 
 33
directly associate with the RyR2 to modulate its activity in rabbit heart (Currie et al., 
2004).  The functional consequences of each of these phosphorylation events in the 
normal heart is a facilitation of the Ca2+ current through L-type Ca2+ channels, increased 
reloading of the SR by relieving PLB-mediated inhibition of SERCA, and an increased 
open probability of the RyR.  This allows the heart to function at higher rates, such as 
during β-adrenergic stimulation.  This acute activation of the β-adrenergic system results 
in the “fight-or-flight” response causing positive chronoptropy and inotropy.  However, 
in cases of heart failure where the CaMKII is upregulated (Ai et al., 2005) and β-
adrenergic stimulation is chronic due to the decreased contractility, CaMKII 
phosphorylation of RyR causes increased leak during diastole and can lead to delayed 
after depolarizations (DADs) and triggered arrhythmias.    It was shown that inhibition of 
CaMKII could completely abolish these effects, thus it possible this phenomenon is 
regulated entirely by CaMKII (Curran et al., 2010).  One hypothesis for the activation of 
CaMKII by β-adrenergic stimulation is that the increased frequency and magnitude of 
Ca2+ signals in the cytosol arising from β-adrenergic stimulation can activate the CaMKII 
enzyme (Grimm and Brown, 2010).  Of significance, the nuclear-localized CaMKII may 
be activated in the same way; however, the source of the activating Ca2+ has been shown 
to come from InsP3-induced Ca2+ release (IICR) from nuclear InsP3Rs (Wu et al., 2006). 
As stated above, CaMKII activity and expression were found to be increased in 
human heart failure (Hoch et al., 1999; Kirchhefer et al., 1999).  The function effects of 
acute and long-term overexpression of CaMKII were examined in the heart to determine 
its effects on the Ca2+ signaling causing initiation and progression of heart failure.  The 
overexpression of CaMKIIδC in the mouse heart caused contractile dysfunction and heart 
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failure.  Ryanodine receptor phosphorylation was increased even before development of 
heart failure. As typically seen in heart failure, SR Ca2+ content was also decreased, and 
sodium/calcium exchanger (NXC) activity was increased.  Furthermore, phospholamban 
phosphorylation specifically at the CaMKII site was increased, thus providing evidence 
for the involvement of CaMKIIδC activation in the pathogenesis of heart failure (Zhang et 
al., 2002).  In addition to the effects of CaMKIIδC, CaMKIIδB was found to lead to 
cardiac hypertrophy and heart failure.  CaMKIIδB transgenic mice developed cardiac 
hypertrophy and changes in gene expression consist with development of a dilated 
cardiomyopathy.  This supports the hypothesis that CaMKIIδB can function within the 
nucleus to upregulate the expression of genes leading to hypertrophy (Zhang et al., 2002).  
It was also recently shown that acute adenonviral-mediated overexpression of CaMKIIδB 
can cause the translocation of HDAC4 out of the nucleus.  This results in the de-
repression of hypertrophic genes and thus could contribute to the onset or progression of 
heart failure (Bossuyt et al., 2008). 
 
 4. CaMKII Interaction and Modulation of InsP3R2 
The type 2 inositol 1,4,5-trisphosphate receptor isoform is the predominant 
isoform expressed in atrial and ventricular myocytes. The majority of InsP3R2 is 
localized to the nuclear envelope in ventricular myocytes, where it has been hypothesized 
to play a role in calcium-dependent nuclear specific signaling.  Using nuclei isolated from 
rat hearts, Bare et al. (2005) have shown that the InsP3R2 is an integral nuclear envelope 
Ca2+ release channel, implying a specific and unique role for the InsP3R2 in regulating 
nuclear Ca2+ transients.  Furthermore, the receptor forms a complex with recombinant 
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CaMKII in vitro and with endogenous CaMKII in vivo.  It was also shown that the 
receptor is a substrate for the kinase.  Full-length recombinant InsP3R2 
immunoprecipitated from COS-1 cells could be phosphorylated by exogenously supplied 
CaMKII.  This phosphorylation could be inhibited by KN-93, a CaMKII inhibitor.  The 
same was shown for the type 2 carboxyl terminal truncated construct that only contained 
the first 1078 amino acids.  Phosphorylation of the receptor by CaMKII in a cellular 
context was also demonstrated in cardiac nuclei.  No exogenous CaMKII was supplied 
and the phosphorylation state of immunoprecipitated InsP3R2 was evaluated.  The native 
InsP3R2 had 32P label incorporated, which could be decreased by addition of KN-93, 
suggesting that this is a physiological relevant phosphorylation process that takes place in 
the nuclei of myocytes.  Furthermore, the expressed recombinant InsP3R2 was 
phosphorylated by exogenous CaMKIIδB, resulting in a dramatic decline in open 
probability of the channel when incorporated into planar lipid bilayers for single channel 
analysis.  The open probability was profoundly reduced, from ~0.43 to 0.04, when 
pretreated with CaMKII.  As a result, there was a 12-fold increase of the channel mean 
close time.  This effect could be abolished by the addition of the CaMKII inhibitor KN-
93, suggesting the effect was a result of phosphorylation of the channel (Bare et al., 
2005).  These studies support the hypothesis that IP3-dependent Ca2+ release via the 
InsP3R2 localized to the nuclear envelope in adult ventricular myocytes may activate 
CaMKIIδB that is in complex with the receptor.  Activated CaMKIIδB can signal to 
downstream molecules, such as HDAC5, and also negatively feedback on InsP3R2 
function, resulting in a decrease in channel activity.   
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Wu et al. (2006) investigated the InsP3R2s in ventricular myocytes and the 
receptor’s functional relationship with CaMKIIδB and one of its downstream targets, 
HDAC5.  It had been shown previously that CaMKII can phosphorylate type II histone 
deacetylases (HDAC 4, 5, 7, 9), which normally act to repress gene expression by 
favoring condensed DNA (McKinsey et al., 2000).  Phosphorylated HDAC is transported 
from the nucleus, allowing hypertrophic gene expression activation.  An InsP3R 
antagonist, 2-APB, blocked HDAC5 nuclear transport, while adenophostin (InsP3R 
agonist) and ET-1 (InsP3 production agonist) induced HDAC5 transport from the nucleus.  
Depletion of nulear envelope Ca2+ stores with thapsigargin (TG) abolished the effect of 
ET-1 on HDAC5 nuclear export.  Notably, the normal beat-to-beat global fluctuations in 
[Ca2+]i in the myocyte responsible for ECC were not able to activate the CaMKII 
responsible for the phosphorylation of HDAC5, suggesting a very specific and localized 
signaling microdomain.  Also, the CaMKII inhibitor KN-93 partially blocked HDAC5 
nuclear export.  Endothelin-1 and adenophostin were shown to induce 
autophosphorylation of CaMKII in permeabilized myocytes, with both effects being 
blocked by the InsP3R inhibitor, 2-APB.  This provides a role for the InsP3R2 in the 
activation of CaMKII (Wu et al., 2006).  These data discussed above support a 
hypothesis of local Ca2+ release via InsP3R2 activating CaMKIIδB coupled to the receptor 
in a macromolecular signaling complex, allowing the activated CaMKII to act on 
downstream targets and feedback on the activity of the InsP3R2 in a nuclear signaling 
cascade leading to expression of hypertrophic genes and heart failure.  Thus, the feedback 
regulation of CaMKII-mediated phosphorylation of the InsP3R2 is an important part of 
the pathway and may serve as a way to terminate the nuclear IP3-dependent Ca2+ signal.   
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CHAPTER TWO 
AIMS AND HYPOTHESIS 
 
The hypothesis to be tested is that activated CaMKII feedback modulates the 
InsP3R2 via direct phosphorylation, and disruption of those sites can abolish 
phosphorylation and the resulting functional consequences.  This study will give us a 
better functional understanding of how the InsP3R and CaMKII macromolecular complex 
is regulated and will be accomplished by the following specific aims. 
 
 
Specific Aim 1:  Identify Putative CaMKII Phosphorylation Sites on the 
InsP3R2 
This Aim will be accomplished by identifying through 32P-incorporation which 
InsP3R2 fragments are phosphorylated by CaMKII.  Recombinant proteins will be treated 
with exogenous CaMKII enzyme to determine which ones can be phosphorylated by 
CaMKII.   
 
 
Specific Aim 2:  Mutagenize Putative CaMKII Phosphorylation Sites on the 
InsP3R2 
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This Aim will be accomplished by mutagenizing potential CaMKII 
phosphorylation sites identified in Aim 1 and using those constructs in 32P-incorporation 
assays to determine if mutation of specific amino acid residues can abolish CaMKII-
mediated phosphorylation of the InsP3R2. 
 
 
Specific Aim 3:  Test the Hypothesis that Ablation of a CaMKII 
Phosphorylation Site in Full-length InsP3R2 Affects the Functional Characteristics 
of the Channel  
This Aim will be accomplished by using single channel recordings of 
recombinant WT, non-phosphorylatable, and phosphomimetic InsP3R2 channels in planar 
lipid bilayers and evaluating the channel’s open probability and subconductance states in 
the presence and absence of activated CaMKII.   
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CHAPTER THREE 
MATERIALS AND METHODS 
 
A.  REAGENTS 
Reagents used were obtained from the following vendors: Ins(1,4,5)P3 was 
obtained from Alexis (San Diego, CA).  All restriction enzymes, DNA ligase, and DNA 
phosphatase used for molecular cloning were obtained from New England Biolabs 
(Ipswich, MA).  PP1 and PP2A were from Sigma Aldrich (St. Louis, MO).  Dulbecco’s 
modified eagle medium (DMEM), HyClone TNM-FH insect cell medium, fetal bovine 
serum (FBS), penicillin-streptomycin, and trypsin used for tissue culture and cell 
propagation were obtained from Cellgro/Mediatech (Herndon, VA).  All other chemicals 
used were reagent grade. 
 
B.  PLASMID CONSTRUCTION 
1a. InsP3R2: Full length 
The construction of the full-length type 2 InsP3R protein expression vector 
(pInsP3R2) was described in total previously (Ramos-Franco et al., 2000).  Briefly, the 
expression plasmid was assembled using overlapping cDNA clones originally isolated 
from a rat brain library (Sudhof et al., 1991).  The fully expressed protein includes amino 
acid residues 1-2701 from the rat type 2 cDNA (accession number X61677). 
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 1b. InsP3R2: pInsP3R2-Stop1078 
The pIP3R2-Stopl078 construct is a mammalian expression vector of the first 
1078 amino acids of the type-2 InsP3 receptor. This sequence is followed by the 12 
carboxy-terminal amino acids of the 116K subunit of the proton pump and was 
previously described (Sudhof et al., 1991).  Briefly, pIP3R2-Stopl078 was constructed by 
cloning a 2.45 kb EcoRl-KpnI fragment followed by the 1.04 kb KpnI-PstI fragment of 
InsP3R2 into pCMV2 followed by an oligonucleotide encoding the carboxy-terminal 
proton pump epitope.  The fully expressed protein includes amino acid residues 1-1078 
from the rat type 2 cDNA (accession number X61677). 
 
 1c. InsP3R1-Stop 1081 
The pInsP3R1-Stop 1081 construct is a mammalian expression vector of the first 
1081 amino acids of the InsP3R1.  This sequence is followed by the 12 carboxy-terminal 
amino acids of the 116K subunit of the proton pump and was previously described 
(Mignery and Sudhof, 1990).  Briefly, the oligomerized nucleotides encoding the proton 
pump tag followed by a stop codon were inserted at a PstI site at 3567 in the pInsP3R1 
construct, thus producing the pInsP3R1-Stop 1081 construct.  
 
2a. InsP3R2 Fragments: Mammalian Expression Vectors 
The pInsP3R2 vector was used as the template in a series of PCR reactions to 
create three mammalian expression vectors of the InsP3R2 carboxy terminal amino acids 
1074-1640, 1635-2118, and 2114-2701 (Remus and Mignery, unpublished).   The 
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fragments were constructed using the following PCR primer pairs (all reverse primers are 
written 5’-3’): 
Fragment 1074-1640  
(forward) GM338-CCGGAATTCTCCGGGGCCCTGCAG 
(reverse) GM339-CCGGAATTCTGGGAACAGTAGCTCCGG 
 
Fragment 1635-2118 
(forward) GM340-CCGGAATTCCCGGAGCTACTGTTCCCA 
(reverse) GM341-CCGGAATTCGTGGCGGGCCAACTG 
 
Fragment 2114-2701 
(forward) GM342-CCGGAATTCCAGTTGGCCCGCCAC  
(reverse) GM343-CCGGAATTCTCAGTGCGGTGGCATGTG  
 
Each of the PCR products were digested with the restriction enzymes SalI, XhoI, and/or 
EcoRI and inserted into a similarly digested pCMV-3Tag-1a vector obtained from 
Stratagene (La Jolla, CA) creating new protein fusions that contained three copies of the 
FLAG epitope on the N-terminus of the InsP3R2 protein fragment (Remus and Mignery, 
unpublished).       
 
2b. InsP3R2 Fragments: Bacterial Expression Vectors 
Regions cloned into the bacterial expression plasmid pET-3a were PCR-amplified 
using pInsP3R2 as template and specific primers engineered to contain and N-terminal 
NdeI restriction site and a C-terminal BglII site in addition to a Methionine inserted 
directly after the NdeI site and a termination codon directly before the the BglII site.  The 
fragments were constructed using the following PCR primer pairs (all reverse primers are 
written 5’-3’): 
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Fragment 1-546  
(forward) GM356-CCATGGGCCATATGTCTGACAAAATGTCCAGCTTCC  
(reverse) GM362-GGCCAGATCTTAATAGCGCTGGTCGCCCAGGTCC  
 
Fragment 234-1078 
(forward) GM361-GGCCATATGAAGTTCAGCTCCTACCGA  
(reverse) GM357-GGCCGAAGATCTTACTGCAGGGCCCCGG  
 
Fragment 320-1078 
(forward) GM363-GGCCATATGCCTGACTATCGAGATGCTCAA  
(reverse) GM357-GGCCGAAGATCTTACTGCAGGGCCCCGG  
 
Fragment 1-338  
(forward) GM356-CCATGGGCCATATGTCTGACAAAATGTCCAGCTTCC 
(reverse) GM364-GGCCAGATCTTATGGAAGCTCCCCGTCTCTCAC  
 
Fragment 106-338 
(forward) GM368-GGCCATATGGAGAACAAGAAACTTTTGGGAGAAATT 
TTG 
(reverse) GM364-GGCCAGATCTTATGGAAGCTCCCCGTCTCTCAC 
 
Fragment 134-338 
(forward) GM369-GGCCATATGGTGAACAAGAGGTTACCTGCCTTACTGG 
AGAAG 
(reverse) GM364-GGCCAGATCTTATGGAAGCTCCCCGTCTCTCAC 
 
Fragment 151-338 
(forward) GM374-GGCCTGCTGGATGCTGCAGGGAACGAAGGGTCCTGG  
(reverse) GM364-GGCCAGATCTTATGGAAGCTCCCCGTCTCTCAC 
 
Fragment 172-338 
(forward) GM370-GGCCATATGGAGGGTGATAATATCGTCGTGGGAGAT 
AAAGTC  
(reverse) GM364-GGCCAGATCTTATGGAAGCTCCCCGTCTCTCAC 
 
PCR products were then digested with NdeI/BglII and ligated into NdeI/BamHI 
digested pET-3a plasmid to form the various bacterial expression plasmids.  
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C.  SITE-DIRECTED MUTAGENESIS 
Mutagenesis was performed using Change-IT Multiple Mutation Site-Directed 
Mutagenesis Kit (USB Corp.).  Bacterial expression vectors described above were used 
as templates for the mutagenic PCR reactions.  Primer pairs were designed to bind to 
unique sites on the template, with the bases coding for the mutation located in the middle 
of the primer and flanked by 10-15 bases complementary to the template DNA.  For each 
mutagenic reaction, primer pairs had to bind to opposite strands of the DNA template.  
After the mutagenic PCR reaction, the template DNA was digested with DpnI enzyme for 
1 hour at 37˚C to reduce background colonies when the reaction was transformed.  DH5α 
E. coli cells (Invitrogen) were transformed with 1µl of the digested PCR reactions.  Cells 
were plated on agar plates with the appropriated antibiotic for growth of transformed 
cells and incubated overnight at 37˚C.  Colonies were then selected and propagated for 
extraction of the transformed DNA plasmids.  Plasmids isolated from the bacterial cells 
were sequenced to confirm that they contained the desired mutations. 
 
D.  DNA SEQUENCING 
Newly synthesized plasmid DNA constructs were verified by DNA sequence 
analysis using a commercial facility at University of California Davis (Davis Sequencing) 
using the Applied Biosystems Big Dye Terminator V3.0 sequencing chemistry. 
 
E.  COS-1 CELL TRANSFECTION 
 
COS-1 cells were transiently and singly transfected with the expression plasmids 
for pInsP3R2, pInsP3R2-S150A, pInsP3R2-S150E, pIP3R2-Stop1078, and with the 
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mammalian expression plasmids for amino acids 1074-1640, 1635-2118, and 2114-2701 
described above using a diethyaminoethyl-dextran method (DEAE) as described 
previously (Mignery et al., 1990).  When needed, sheared salmon sperm DNA (ssDNA) 
was used to represent mock transfected cells and serve as a negative control.  Cells were 
incubated at 37° C, 5% CO2 and harvested 48-72 hours post-transfection.   
 
F. HARVESTING OF COS-1 CELLS 
Following the expression period, the COS cells were washed with phosphate 
buffered saline (PBS), harvested by scrapping the cells off the plate in 
immunoprecipitation (IP) buffer (50 mM HEPES, pH 7.6, 1.0% bovine serum albumin 
(BSA), 10 mM magnesium acetate, 50 mM NaCl2, 0.5 mM CaCl2, 1 mM dithiothreitol 
(DTT), 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 100 µg/ml soybean trypsin 
inhibitor, 10 µM leupeptin, and 10 µM pepstatin) and lysed by 20-40 passages through a 
27-gauge needle.  The membranes were pelleted by centrifugation using a Beckman fixed 
angle rotor (TLA-110) at 4º C for 10 minutes at 135,000 x gmax and the supernatant 
containing the soluble protein fraction was removed from the microsomes.  To solubilize 
any membrane bound proteins, the membrane fraction was resuspended in IP Buffer with 
the addition of 1.0% Triton X-100 and incubated on ice with stirring for 1-2 hours 
followed by removal of insoluble material by centrifugation at 135,000 x gmax at 4º C.   
 
G. BACTERIAL CELL EXPRESSION 
E. coli Rosetta 2 (DE3) competent cells (Novagen) were transformed with the 
various bacterial expression plasmids and grown at 37˚C with shaking in liquid culture 
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until OD600 reached 0.6.  Isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a 
final concentration of 1 mM and the culture was incubated for 3 hours at 37˚C with 
shaking for induction of protein production.   
 
H. INCLUSION BODY PURIFICATION AND SOLUBILIZATION 
After incubation for protein production, cells were pelleted at 3220 x gmax for 20 
min. and resuspended in lysis buffer (8% Sucrose, 0.5% Triton X-100, 10 mM Tris-Cl pH 
8, 50 mM EDTA, 1 mM PMSF) with 10 mg/mL Lysozyme (Sigma) and incubated at 
room temperature with agitation for 20 min.  The lysate was then homogenized by hand 
and 1 mg/mL DNase and 100 mg/mL RNase were added and the solution was incubated 
at room temperature for 25 min with agitation.  The sample was then spun at 12000 x 
gmax for 10 min., and the pellet was washed with Wash Buffer (0.5M NaCl, 0.5% Triton 
X-100, 1 mM PMSF).  This was repeated twice with the final wash containing 1 M urea.  
The resulting inclusion body pellet was then solubilized in solubilization buffer (8 M 
Urea, 150 mM NaCl, 50 mM Tris-Cl pH 7.4, 3 mM 2-Mercaptoethanol, 3 mM DTT) and 
insoluble material was pelleted by centrifugation at 106,000 x gmax for 10 min.  Soluble 
material was transferred to a dialysis bag (MWCO=12 kDa) and dialyzed against 4 L of 
dialysis buffer (150 mM NaCl, 50 mM Tris-Cl pH 7.4, 2 mM 2-Mercaptoethanol) to 
remove the urea and allow refolding of recombinant proteins for downstream 
applications.  Recovered material was cleared by centrifugation at 106,000 x gmax for 10 
min and the lysate containing the purified, refolded proteins was stored at 4˚C. 
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I. IMMUNOPRECIPITATION OF RECOMBINANT PROTEINS 
The supernatant from COS-1 cells (containing recombinant proteins from either 
solubilized membrane fractions or the cytosolic fractions of lysed cells) or the purified, 
refolded bacterially expressed proteins were divided into equal volume aliquots, and the 
appropriate primary antibodies were added and incubated overnight at 4º C with agitation.  
Protein-A Sepharose CL-4B beads (Amersham Biosciences) were added, and incubated 
for 2 hrs. at 4º C with agitation.  Immune complexes were then washed three times with 
IP buffer before addition of kinase. 
 
J. CAMKII PHOSPHORYLATION OF RECOMBINANT PROTEINS 
IP complexes were used as substrates for CaMKII phosphorylation in the in vitro 
32P incorporation assays.  Immune complexes were incubated at 30˚C for 20 min with 
500 units of exogenous pre-activated CaMKII (New England Biolabs) or with 10 µM of 
the specific CaMKII inhibitor, KN-93 (Seikagaku Corp.)  The reaction buffer (50 mM 
Tris-HCl pH 7.5, 10 mM MgCl2, 2 mM DTT, 0.1 mM Na2EDTA, 2 mM CaCl2, 1.2 µM 
Calmodulin, 200 µM ATP) was supplemented with [γ-P32]ATP to a final specific activity 
of 200 µCi/µmol for visualization of phosphorylated proteins via autoradiography.   
 
K.  ANTIBODIES 
The InsP3R2-specific antibodies T1NH, T2NH and T2C have been previously 
described.  The T1NH antibody is directed against the sequence 
CLATGHYLAAEVDPDQDASR (amino acids 308-341).  The T2NH and T2C 
antibodies are directed against the sequences CPDYRDAQNEGKTVRDGELP (amino 
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acids 320-338) and CNKQRLGFLGSNTPHENHHMPPH (amino acids 2679-2701) of 
the rat InsP3R2, respectively (Ramos-Franco et al., 1998a and 1998b).  These three 
InsP3R-specific rabbit polyclonal antibodies were affinity purified using immunogenic 
peptides. Anti-FLAG antibody was purchased from Affinity BioReagents and is a rabbit 
polyclonal against the peptide DYKDDDDKC.   
 
L.  SDS-PAGE AND WESTERN BLOTTING 
SDS-PAGE and Western blotting were performed as previously described 
(Mignery et al., 1990) using 5%, 7.5%, or 10% SDS-polyacrylamide gels.  Western 
blotting was performed by electro-transfer of the resolved proteins to Osmonics 
Nitrobind nitrocellulose (Fisher Scientific; Pittsburgh, PA.) at 250 mA for 1 hour at 4º C 
in Transfer Buffer (192 mM glycine, 25 mM Tris-HCl, and 20% methanol).  Following 
transfer, the nitrocellulose was blocked and blotted using the ReliaBLOT IP/Western Blot 
Reagent Kit (Bethyl Laboratories; Montgomery, TX).  ReliaBLOT Block was 
reconstituted in TBST (150 mM sodium chloride, 10 mM Tris-HCl, 0.05% Tween-20, pH 
8.0) and the nitrocellulose was placed in this solution for 30 minutes at room temperature 
on a rocking platform.  The primary antibodies were diluted in ReliaBLOT Block/TBST 
at dilutions ranging from 1:3000 to 1:5000 and added to the nitrocellulose and allowed to 
incubate overnight with shaking.  After the primary antibody incubation, the 
nitrocellulose was washed three times with TBST.  ReliaBLOT Horseradish Peroxidase 
(HRP) Conjugate secondary antibody was diluted 1:3000 in ReliaBLOT Block/TBST and 
then added to the nitrocellulose to incubate for 45 minutes to 1 hour.  The nitrocellulose 
was washed three times with TBST.  Visualization was accomplished using enhanced 
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chemi-luminescence (ECL) reagents (GE Healthcare).  Visualization of 32P-labeled 
proteins was done by exposing the dried nitrocellulose to laboratory film (Kodak) for 
periods of 4-24 hours.  Films were developed using an automatic film developer.  
 
M.  SF9 CELL CULTURE AND BACULOVIRUS INFECTION 
Sf9 cells were grown in 75 cm2 tissue culture flasks in culture medium containing 
TNM-FH Medium (Cellgro) and 10% Fetal bovine serum.  Cells were split every 3 days.  
Liquid cultures of Sf9 cells in TNM-FH medium were also used to increase cell numbers 
quickly.  These cultures were typically between 100-200 mL and incubated at 27 ˚C with 
shaking for 24-48 hrs.  Cells were plated onto the flasks again prior to baculoviral 
infection.  A baculovirus expressing the full-length rat type 2 InsP3R (RT2, kindly 
provided by Dr. Iyla Bezprozvanny) was added to the medium of flasks containing Sf9 
cells at a multiplicity of infection of 1 (MOI=1) and cells were incubated at 27 ˚C for 72 
hours to allow for expression of recombinant protein. 
 
N.  PREPARATION OF MICROSOMES FOR LIPID BILAYERS   
Microsomes from Sf9 and COS-1 cells were prepared for use in planar lipid 
bilayers as previously described (Kaznacheyeva et al., 1998).  Briefly, COS-1 or Sf9 cells 
were harvested in homogenization buffer (50 mM Tris-HCl, pH 8.3, 1 mM EDTA, 5 mM 
sodium azide, 0.25 mM PMSF, 10 µM leupeptin, 10 µM pepstatin, 100 µg/ml trypsin 
inhibitor) and lysed with a glass/Teflon Potter-Elvehjem tissue grinder. An equal volume 
of buffer containing 0.5 M sucrose was added, and the material was re-homogenized and 
centrifuged for 5 min at 1,200 x gmax. The supernatant containing the microsomes was 
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recovered, and KCl and disodium pyrophosphate were added to a final concentration of 
0.6 M and 20 mM, respectively. The material was homogenized and mixed for 30 min at 
4 °C. Following a final homogenization, the microsomes were centrifuged for 5 min at 
200 x gmax, and the supernatant was recovered. Finally, the microsomes were pelleted at 
100,000 x gmax for 10 min, resuspended in storage buffer containing 10% sucrose, and 
snap-frozen and stored in liquid nitrogen. 
 
O.  PLANAR LIPID BILAYERS 
Single channel recordings of recombinant InsP3R type 2 activities were 
performed by fusing microsomes into planar lipid bilayers. Bilayers were formed across a 
150 µm diameter hole in the wall of a Delrin cup using a 7:3 lipid mixture of 
phosphatidylethanolamine and phosphatidylcholine (stock concentrations of 50 mg/ml in 
decane were used, Avanti Polar Lipids, Alabaster, AL). The bilayer separated two pools 
(cis and trans). The microsomes were added to the cis-side of the bilayer. Standard 
solution contained 20 mM HEPES-Tris, pH 7.4, 1 mM EGTA, [Ca2+]FREE = 250 nM, and 
220 mM CsCH3SO3 in the cis-chamber (20 mM CsCH3SO3 in the trans). Free calcium 
concentration was calculated using MaxChelator software. 2 µM InsP3 was used in the 
cis side. The trans pool was held at virtual ground. The channels were positively 
identified by their sensitivity to InsP3. Unitary currents were recorded using a 
conventional patch clamp amplifier (Axopatch 200B, Axon Instruments, Union City, 
CA). The current signal was digitized at 10 kHz with a 32-bit AD/DA converter 
(Digidata 1322A, Axon Instruments) and filtered at 1 kHz with a low pass eight pole 
Bessel filter. Data acquisition, unitary current measurement, statistical analysis, and data 
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processing were performed using commercially available software packages (pClamp 
V10.2, Axon Instruments and OriginPro 7, Microcal). 
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CHAPTER FOUR 
IDENTIFICATION OF THE CAMKII PHOSPHORYLATION SITE ON THE 
TYPE 2 INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR 
 
A.  INTRODUCTION 
 
To determine the exact site of phosphorylation of the InsP3R2 by CaMKII, I used 
exogenously expressed fragments of the InsP3R2 in in vitro phosphorylation assays.  
Figure 5 shows a diagram of the fragments of the InsP3R2 I used in these assays.  
Fragments containing a FLAG-tag were expressed in COS-1 cells, while the remaining 
fragments were expressed in bacterial cells.  The recombinant proteins were treated with 
exogenous CaMKII in the presence of radioactive ATP (γ32P-ATP).  These reactions 
were resolved by polyacrylamide gel electrophoresis and phosphorylated proteins were 
determined by autoradiography.  The results of these experiments identified a single 
potential CaMKII site based on the minimal InsP3R2 fragment that was phosphorylated 
by CaMKII.  This phosphorylation site was abolished by site-directed mutagenesis of the 
Serine residue to the small, non-charged amino acid Alanine, which has no hydroxyl side 
group for a phosphate group to be attached to.  This has been proven to be a reliable and 
successful method to inhibit phosphorylation of a residue while not disrupting the 
structure or function of the recombinant protein.  Mutation of Serine 150 to Alanine 
successfully abolished CaMKII-dependent phosphorylation of two different InsP3R2 sub-
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fragments that were tested.  In addition, this mutation was made in the full-length rat 
InsP3R2, and it was able to prevent CaMKII-mediated phosphorylation of the 
recombinant full-length InsP3R2 in vitro.  These results unambiguously identify Serine-
150 of the rat InsP3R2 as the CaMKII phosphorylation site.  Furthermore, these results 
suggest that this is the only CaMKII phosphorylation site present on the InsP3R2 since 
mutagenesis of this site completely abolished CaMKII-mediation phosphorylation.   
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Figure 5: InsP3R2 fragments used in phosphorylation assays 
 
The colored regions of the full-length rat InsP3R2 represent the ligand binding domain 
(red), and coupling/modulatory domain (green), and the channel domain (blue).  All 
fragments were generated by PCR amplication using full-length InsP3R2 as template. 
Those containing an N-terminal FLAG-tag (yellow) were created with restriction sites for 
insertion into the pCMV-3Tag-1A vector. Those not containing the FLAG-tag were 
created with restriction sites for insertion into the pET-3a vector for bacterial cell 
expression. 
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B. RESULTS 
1. CaMKII-dependent phosphorylation of pInsP3R2-Stop1078 
It has been shown previously in our lab that CaMKII could phosphorylate a 
fragment spanning amino acids 1-1078 of the InsP3R2 (Bare et al., 2005).  This is shown 
in Figure 6 along with the rest of the fragments spanning the entire InsP3R2 protein.  The 
fragments were expressed in COS-1 cells and recombinant proteins were 
immunoprecipitated with an amino terminal antibody (T2NH, for pInsP3R2-Stop1078) or 
anti-FLAG antibody (for 1074-1640, 1635-2118, and 2114-2701).  Prior to 
immunoprecipitation, the 2114-2701 fragment had to be solubilized from the microsomal 
fraction since it contains the 6 transmembrane regions.  Immunoprecipitated complexes 
were then treated in the presence of radioactive ATP with exogenously supplied pre-
activated CaMKII (500 units) or the specific CaMKII inhibitor KN-93 (10 µM), resolved 
on 7.5% SDS-PAGE, transferred to nitrocellulose membrane, and autoradiographed and 
Western blotted.  As shown in Figure 6, the fragment spanning amino acids 1-1078 was 
the only one that showed 32P-incorporation upon treatment with CaMKII.  This effect was 
blocked when KN-93 was used.  These data show that the CaMKII phosphorylation site 
on the InsP3R2 lies in the N-terminal 1078 amino acids and no other CaMKII sites are 
present downstream of amino acid 1078.   
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Figure 6: CaMKII-dependent phosphorylation of InsP3R2 fragment 1-1078 
 
 
CaMKII phosphorylation assays performed using IPs of InsP3R2 subfragments expressed 
in COS-1 cells as substrates reveal that the fragment spanning amino acids 1-1078 is 
phosphorylated by CaMKII. Reactions were carried out with the addition of exogenous 
CaMKII (500 units) or the specific CaMKII-inhibitor KN-93 (10 μM), resolved on 7.5% 
SDS-PAGE, transferred to nitrocellulose, and autoradiographed.  With the addition of 
CaMKII, the 1-1078 construct showed significant incorporation of 32P, while no signal 
could be detected with the 1074-1640, 1635-2118, or 2114-2701 constructs (upper 
panel). Western blotting of the membrane with T2NH (1-1078) or anti-FLAG (1074-
1640, 1635-2118, and 2114-2701) antibody confirmed the success and uniformity of 
immunoprecipitations used in the phosphorylation reactions (lower panel). The results 
suggest that the CaMKII phosphorylation site on the InsP3R2 lies in the N-terminal 1078 
amino acids and no other CaMKII sites are present downstream of amino acid 1078. 
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2. CaMKII-dependent phosphorylation of bacterially expressed 
InsP3R2 fragments 
To further elucidate the site of CaMKII modulation of the InsP3R2, I used four 
bacterially expressed fragments spanning amino acids 1-1078 (Figure 5).  As shown in 
Figure 7, the 1-546 and 1-338 constructs showed significant incorporation of 32P after 
CaMKII treatment, while no signal could be detected with the 234-1078 and 320-1078 
constructs.  This CaMKII effect on the 1-546 and 1-338 constructs could be inhibited 
with KN-93.  These results suggest that the CaMKII phosphorylation site on the InsP3R2 
lies within amino acids 1-234.   
The last four fragments (shown in Figure 5) were created as N-terminal deletions in 
order to preserve the T2NH antibody epitope (amino acids 320-338) for 
immunoprecipitating the proteins.  As shown in Figure 8, the 106-338 and 134-338 
constructs showed significant incorporation of 32P, along with the 1-338 fragment as 
shown previously.  No significant signal could be detected with the 172-338 construct.  
These results suggest that the CaMKII phosphorylation site on the InsP3R2 lies within 
amino acids 134-171.  In addition, a fragment spanning amino acids 151-338 could not be 
phosphorylated by CaMKII.  These results suggest the CaMKII phosphorylation site is 
located within amino acids 134-150 of the InsP3R2.   
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Figure 7: CaMKII-dependent phosphorylation of bacterially expressed InsP3R2 
fragments 1-338 and 1-546.  
 
CaMKII phosphorylation assays performed using IPs of bacterially expressed InsP3R2 
subfragments as substrates reveal that fragments spanning amino acids 1-546 and 1-338 
are phosphorylated by CaMKII. Reactions were carried out with the addition of 
exogenous CaMKII (500 units) or the specific CaMKII-inhibitor KN-93 (10 μM), 
resolved on 12.5% SDS-PAGE, transferred to nitrocellulose, and autoradiographed.  With 
the addition of CaMKII, the 1-546 and 1-338 constructs showed significant incorporation 
of 32P, while no signal could be detected with the 234-1078 and 320-1078 constructs 
(upper panel). Western blotting of the membrane with T2NH antibody confirmed the 
success and uniformity of immunoprecipitations used in the phosphorylation reactions 
(lower panel). The results suggest that the CaMKII phosphorylation site on the InsP R2 
lies within amino acids 1-234. 
3
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Figure 8: CaMKII phosphorylation of InsP3R2 N-terminal deletion fragments 
 
CaMKII phosphorylation assays performed using IPs of bacterially expressed 
InsP3R2 subfragments as substrates reveal that fragments spanning amino acids 
106-338 and 134-338 are phosphorylated by CaMKII. Reactions were carried out 
with the addition of exogenous CaMKII (500 units) or the specific CaMKII-
inhibitor KN-93 (10 μM), resolved on 12.5% SDS-PAGE, transferred to 
nitrocellulose, and autoradiographed.  With the addition of CaMKII, the 106-338 
and 134-338 constructs showed significant incorporation of 32P, along with the 1-
338 fragment as shown previously. No significant signal could be detected with the 
151-338 or the 172-338 constructs (upper panel). Western blotting of the 
membrane with T2NH antibody confirmed the success and uniformity of 
immunoprecipitations used in the phosphorylation reactions (lower panel). The 
results suggest that the CaMKII phosphorylation site on the InsP3R2 lies within 
amino acids 134-150. 
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3. CaMKII can Phosphorylate InsP3R2 at Serine-150 
The results from Figure 8 indicate that the CaMKII phosphorylation site on the 
InsP3R2 lies within amino acids 134-150.  Within this span of amino acids, there is one 
potential CaMKII site located at Serine-150.  This Serine is part of an S-x-D motif in the 
InsP3R2.  This motif was shown to be the CaMKII-dependent phosphorylation site on the 
RyR2 (Wehrens et al., 2004).  Site-directed mutagenesis was performed to mutate the 
Serine at residue 150 to Alanine to abolish phosphorylation in two of the fragments 
previously shown to be phosphorylated by CaMKII.   Figure 9 shows that this resulted an 
observable decrease in the 32P-incorporation of the fragments containing the S150A 
mutation when treated with active CaMKII.   
The S150A mutation was also made in the full-length InsP3R2 protein for use in 
an in vitro kinase assay in Figure 10.  Upon treatment with CaMKII, the InsP3R2-S150A 
showed no 32P-incorporation when compared to the InsP3R2-WT protein that could be 
phosphorylated by exogenously supplied CaMKII.  These results presented above clearly 
identify Serine-150 as the CaMKII phosphorylation site on the InsP3R2.  Furthermore, it 
can be concluded that this is the only CaMKII phosphorylation site present on the 
InsP3R2 since mutagenesis of this site completely abolished CaMKII-mediation 
phosphorylation of the full-length protein.  
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Figure 9: CaMKII can phosphorylate the InsP3R2 fragments on Serine-150 
 
CaMKII phosphorylation assays performed using IP’d bacterially expressed InsP3R2 
fragments as substrates (upper panel) show that mutation of Ser150? Alanine could 
abolish CaMKII-mediated phosphrylation of Fragments 1-338-S150A and 134-338-
S150A. Fragments 1-338 and 134-338 not containing the mutation showed significant 
incorporation of 32P when treated with CaMKII. Reactions were carried out with the 
addition of exogenous CaMKII (500 units) or the specific CaMKII-inhibitor KN-93 
(10 μM), resolved on 12.5% SDS-PAGE, transferred to nitrocellulose, and 
autoradiographed. Western blotting of the membrane with T2NH antibody confirmed 
the presence of similar protein amounts within samples used in the phosphorylation 
reactions (lower panel). The results show that CaMKII can phosphorylate InsP3R2 
fragments on Ser150 and mutation of this site abolishes all CaMKII-mediated 
phosphorylation of the fragments. 
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Figure 10: CaMKII can phosphorylate the full-length InsP3R2 on Serine-150 
 
CaMKII phosphorylation assays performed using full-length InsP3R2 expressed in 
COS-1 cells as substrates show that mutation of Ser150? Alanine could abolish 
CaMKII-mediated phosphrylation of full-length InsP3R2-S150A (upper panel). 
Full-length InsP3R2 not containing the mutation showed significant incorporation of 
32P when treated with CaMKII. Reactions were carried out with the addition of 
exogenous CaMKII (500 units) or the specific CaMKII-inhibitor KN-93 (10 μM), 
resolved on 5% SDS-PAGE, transferred to nitrocellulose, and autoradiographed. 
Western blotting of the membrane with T2NH antibody confirmed the presence of 
similar protein amounts within samples used in the phosphorylation reactions 
(lower panel). The results show that Ser150 is the CaMKII phosphorylation site on 
the InsP3R2. 
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C. DISCUSSION 
Phosphorylation of the InsP3R2 by CaMKII represents an important physiological 
mechanism by which CaMKII can modulate the activity of the InsP3R2.  This study is the 
first to identify the precise site of CaMKII phosphorylation on the InsP3R2.  The results 
presented above show that CaMKII can phosphorylate the InsP3R2 on Ser150.  Figure 10 
shows that mutation of this residue can completely prevent CaMKII-mediated 
phosphorylation of the InsP3R2, indicating that this is the only site that CaMKII 
phosphorylates on the InsP3R2.  This particular Serine residue is part of an S-x-D motif 
that was also found to be a target for CaMKII phosphorylation in the RyR2 (Wehrens et 
al., 2004).  The conservation of this region in the other isoforms of the InsP3R2 and other 
CaMKII substrates is shown in Figure 11.  Homology of the region CaMKII 
phosphorylation site in the InsP3R2 with the RyR2 and can be seen with the actual 
phosphoryation site (S-x-D) along with two alanine residues directly following the S-x-D 
motif.  Furthermore, the Valine directly before Ser-150 is also conserved in the RyR2 and 
the InsP3R1 and InsP3R3.  Interestingly, Serine-150 is conserved as a Threonine in the 
Type 1 and Type 3 InsP3Rs.  No CaMKII-dependent phosphorylation of the InsP3R3 has 
been demonstrated; however, I have shown that CaMKII can phosphorylate the IP3R1 on 
the first 1081 amino acids (Figure 12).  This supports the hypothesis that Thr-150 of the 
InsP3R1 is a potential CaMKII phosphorylation site.  This provides a potential 
mechanism of differential regulation between isoforms given that one is a Serine and the 
other is a Threonine.  CaMKII has not been observed to show any preferential 
phosphorylation of either residue.  The Ca2+-dependence of the type 1 InsP3R is such that  
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Figure 11: Homology of CaMKII phosphorylation sites 
 
CaMKII phosphorylation site alignment with the three isoforms of the InsP3R 
and from various species (mouse, rat, human, bovine) show that Serine-150 of 
the type 2 receptor is conserved as a Threonine in the type 1 and type 3 
receptors.  The region surrounding Ser150/Thr150 is also highly homologous in 
the three isoforms and among species.  The CaMKII phosphorylation sites for 
human RyR2 and HDAC4 are also shown to illustrate the homology the InsP3R2 
Serine-150 site shares with these known CaMKII phosphorylation sites on other 
cardiac proteins.  
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 Figure 12: CaMKII-dependent phosphorylation of InsP3R1 fragment 1-1081 
 
CaMKII phosphorylation assays performed using IPs of InsP3R2 subfragments 
expressed in COS-1 cells as substrates reveal that the fragment spanning amino acids 1-
1081 of the InsP3R1 is phosphorylated by CaMKII. Reactions were carried out with the 
addition of exogenous CaMKII (500 units) or the specific CaMKII-inhibitor KN-93 (10 
μM), resolved on 7.5% SDS-PAGE, transferred to nitrocellulose, and autoradiographed.  
With the addition of CaMKII, the 1-1081 and 1-1078 constructs showed significant 
incorporation of 32P, while this signal could be decreased with KN-93 treatment for 
both the 1-1081 and 1-1078 constructs (upper panel). Western blotting of the 
membrane with T1NH (1-1081) or T2NH (1-1078) antibody confirmed the success and 
uniformity of immunoprecipitations used in the phosphorylation reactions (lower 
panel). The results suggest that a CaMKII phosphorylation site on the InsP3R1 lies in 
the N-terminal 1081 amino acids. 
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high calcium (>1 µM) can begin to inhibit the activity of the receptor, up to 10 µM where 
the receptor is nearly completely inhibited (Ramos-Franco et al., 1998b).  This poses the 
question of what effect CaMKII-mediated phosphorylation has on the properties of the 
InsP3R1 channel.  Looking at the amino acids surrounded Ser150/Thr150 in the type 2 
and type 1 InsP3Rs, it is reasonable to hypothesize that CaMKII phosphorylation of the 
type 1 receptor could have an even greater effect on the function of the channel due to the 
presence of the negatively charged amino acid Glutamate just 3 residues away from the 
phosphorylated Threonine, whereas this residue is the small uncharged amino acid 
Alanine in the InsP3R2.  Upon phosphorylation, the electrostatic repulsion between 
negatively charged phosphate on Threonine-150 and the acidic amino acid Glutamate-
153 of the InsP3R1 could potentially be the greatest of all the isoforms and thus produce 
the greatest functional effects on the activity of the channel.  Elucidation of the 
mechanism of CaMKII-mediated inhibition of channel function of the InsP3R2 will help 
to shed light on what, if any, mechanisms contribute to CaMKII regulation of the InsP3R1 
and the InsP3R3. 
In addition to the local amino acid residues and phosphorylation motifs shown in 
Figure 10, the location of Serine-150 in the larger crystal structure of the suppressor 
domain of the InsP3R2 is shown in Figure 13A.  Based on the resolved crystal structure 
for the protein domain comprising the suppressor domain of the mouse InsP3R1 (Bosanac 
et al., 2005), the location of Serine-150 (or Threonine-150) is shown in Figure 13B.  
Serine-150 is located on β-strand 7, just downstream of a CaM binding site.  
Furthermore, this residue seems to be accessible based on the crystal structure.  It is 
located in close proximity to key residues involved in the interaction between the 
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suppressor domain and the binding core.  The location and the accessibility of this site 
along with the observation that CaMKII phosphorylation inhibits InsP3R2 channel 
activity (Bare et al., 2005), leads into the hypothesis that the mechanism behind CaMKII-
mediated inhibition of the InsP3R2 is that phosphorylation of this residue sterically 
hinders InsP3 binding to the binding core or disrupts the suppressor domain/binding core 
interaction, both of which are critical for gating of the channel.  Based on the location of 
Serine-150, it is possible that the negatively charged phosphate group attached to Serine-
150 can cause a decrease in the affinity of the binding core for InsP3 due to the repulsion 
between the phosphate on Serine-150 and the phosphate groups of InsP3.  The residues of 
the binding core proposed to be important for InsP3 binding are not surprisingly basic, 
positively charged amino acids creating pockets of positive charge for the three 
negatively charged phosphates of InsP3 to interact with.  The addition of the phosphate to 
Serine-150 could perturb one or more of these positively charged pockets, thus 
decreasing the affinity of the receptor for InsP3.  Additionally, this negative charge that 
results from CaMKII-dependent phosphorylation of Serine-150 of the InsP3R2 could 
affect the intramolecular interactions of the LBD, thus creating a structural arrangement 
of the LBD that is unfavorable for transducing ligand binding into channel gating.  
Further discussion on the mechanism of inhibition is found in Chapter Six in light of the 
results showing the functional effects of the phosphomimetic mutation and molecular 
modeling of the effect this mutation has on the ligand binding domain. 
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A. 
B. 
Figure 13: 3-D localization of Serine-150 in the crystral structure of the InsP3R 
suppressor domain 
 
(A) Surface representation of key residues in the suppressor domain involved in inter- 
and intra-molecular interactions.  Regions of interaction of the suppressor domain and 
the InsP3-binding core are shown along with regions of interaction with other proteins 
(figure modified from Bosanac et al., 2004).  (B) Ribbon structure of the suppressor 
domain in similar orientation as in (A).  Residues involved in suppressor 
domain/binding core interaction are highlighted in yellow.  The highlighted and 
circled residue shows the location of Serine-150.  Arrows represent β-strands, while 
the cylinders represent α-helices.  From the structure, it looks as though Serine-150 is 
not only accessible on the surface of the structure, but it is also located in close 
proximity to the residues involved in the suppressor domain/binding core interaction. 
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CHAPTER FIVE 
FUNCTIONAL CHARACTERISTICS OF TYPE 2 INOSITOL 1,4,5-
TRISPHOSPHATE RECEPTOR S150A AND S150E MUTANTS 
 
A.  INTRODUCTION 
To determine what effect phosphorylation of the InsP3R2 by CaMKII had on the 
single channel properties of the receptor, I used exogenously expressed phosphomimetic 
and non-phosphorylatable mutants of the InsP3R2 channel in planar lipid bilayer studies.  
Previous studies have shown that mutation of a phosphorylated residue to a negatively 
charged amino acid such as Glutamate or Aspartate can mimic the effect of 
phosphorylation of that residue (Wehrens et al., 2004).  In the way that mutation of a 
phosphorylatable residue to Alanine leaves the kinase with no hydroxyl group to attach a 
phosphate group to, mutation of the residue to Glutamate or Aspartate creates a residue 
with a negatively charged side group at that position to mimic phosphorylation.  Both 
Glutamate and Aspartate are negatively charged at physiological pH ranges due to pKa’s 
of 4.07 and 3.9, respectively.  In addition, the molecular weight of a phosphorylated 
Serine residue is approximately 166.98 Da (87.08 Da for Serine + 79.90 Da for phosphate 
group), and replication of this change in molecular weight and bulk upon phosphorylation 
is better represented with the 129.12 Da Glutamate compared to the 115.09 Da Aspartate.   
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Planar lipid bilayers represent an excellent system in which to study the single 
channel function of a native or recombinant ion channel.  Channels incorporate into a 
lipid bilayer formed across a small hole separating two chambers.  The concentration of 
ions and other molecules such as agonist can be tightly controlled on each side of the 
bilayer.  In the following results, recordings were done at free Ca2+ concentrations 
([Ca2+]FREE) of 250 nM or greater along with 2 µM InsP3 or greater on the cis (cytosolic 
side) of the bilayer.  These concentrations of agonists have been shown to produce 
maximal activation of the InsP3R2 in similar recordings (Ramos-Franco et al., 1998a and 
1998b).  Theoretically, only an InsP3R2 that incorporates with its ligand binding domain 
facing the cis side would be able to bind the InsP3 there and open, as opposed to channels 
that may incorporate with the LBD facing the trans side where no InsP3 is present.  This 
mimics the InsP3R2 topography in the cellular environment, with the cis side being 
equivalent to the cytoplasmic compartment, while the trans being the lumen of the ER.  
WT and mutant channels were expressed in COS-1 cells, and microsomes were prepared 
from these cells for use in the bilayer recordings.  Cesium (Cs+) is used as the charge 
carrier in all recordings.  In addition to preserving the tight control of [Ca2+] on the cis 
and trans side of the bilayer, Cs+ also inhibits any endogenous potassium (K+) channels 
that may be present contaminating the microsomal preparation.  The hypothesis was that 
the phosphomimetic channel would have a very low Po like that seen with the receptor 
when treated with exogenous CaMKII, while to non-phosporylatable channel would 
show no effect with CaMKII treatment.  Single channel recordings of the S150E mutant 
channel were also performed at various [Ca2+] and [InsP3] in order to gain some further 
mechanistic insight as to the effect of CaMKII-mediated phosphorylation of the InsP3R2.  
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The results presented below confirm that Serine-150 of the InsP3R2 is the modulatory site 
of CaMKII-dependent phosphorylation.  Abolishment of this site prevented the CaMKII-
mediated effects on the function of the InsP3R2.  Furthermore, the phosphomimetic 
mutation produced channels with a very low Po, and also showed some interesting 
features of their Ca2+-sensitivity that may be physiologically relevant and contribute to 
elucidating the mechanism of CaMKII-mediated regulation of the InsP3R2. 
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B.  RESULTS 
1.  Modulation of InsP3R2 activity by CaMKII is revesible with 
phosphatase treatment 
Previous data from our lab has shown that the InsP3R2 and CaMKII form a 
macromolecular complex in cardiac ventricular myocytes and that CaMKII can modulate 
InsP3R2 channel activity (Bare et al., 2005; Wu et al., 2006).  Specifically, InsP3R2 
overexpressing microsomes were phosphorylated in vitro by pre-treatment with active 
CaMKII, and this resulted in a dramatic decrease in the open probability of the channel 
when incorporated into planar lipid bilayers (Bare et al., 2005).  To further investigate the 
role of CaMKII in mediating InsP3R2 activity, planar lipid bilayers were used for single 
channel analysis of the InsP3R2.  Insect Sf9 cells were infected with a baculovirus coding 
for the InsP3R2 (RT2).  Microsomes from the insect cells infected with RT2 baculovirus 
were prepared and used in the planar lipid bilayer single channel recording experiments 
shown in Figure 14.  In Figure 14A, the InsP3R2 channel is recorded under normal 
condition and displayed a Po of approximately 0.37.  Active exogenous CaMKII was 
added to the cis side of the chamber.  This treatment resulted in a decrease in the Po to 
0.09.  The addition of protein phosphatases (PP1 and PP2A) and KN-93 were able to 
relieve CaMKII-mediated regulation of the channel’s activity and the Po returned to 
approximately starting level (0.33).  The control experiment was performed by adding all 
components present in the CaMKII activation mix except the enzyme itself to the bath 
solution and showing these components had no effect on InsP3R2 activity (Figure 14B).  
Figure 14C shows summary bar graphs of the planar lipid bilayer studies. CaMKII  
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Figure 14: Modulation of recombinant InsP3R2 activity by CaMKII is reversible 
with phosphatase treatment.  
 
Representative recordings of InsP3R2 single channels from InsP3R2-baculovirus 
infected Sf9 cell microsomes.  (A) A channel Po of 0.36 was recorded under normal 
conditions. To the bath solution, 1500 units of active CaMKII enzyme were then added 
and recording continued after 20 min. This treatment resulted in a decrease in the Po to 
0.09.  The addition of protein phosphatases (10 units PP1 and 50 ng PP2A) and KN-93 
(30 μM) were able to relieve CaMKII-mediated regulation of the channel’s activity and 
the Po returned to approximately starting level (0.33) after 20 min with treatment. (B) A 
channel Po of 0.38 was recorded under normal conditions. To the bath solution, 
CaMKII reaction buffer alone was added and recording continued after 20 min. This 
treatment resulted in no change in the recorded open probability of the channel. Both A 
& B were taken as representative windows having open probabilities (Po) reflecting the 
10 min recordings used for the actual determination of Po. Channel openings are shown 
as upward deflections from the zero current level. (C) Summary bar graphs of the 
planar lipid bilayer studies. CaMKII treatment resulted in a dramatic decrease in the Po 
of the channel. Reversal of this effect by treatment with protein phosphatases and a 
CaMKII inhibitor is shown. The conditions for this study were 220/20 mM CsCH3SO3 
(cis/trans), [Ca2+]FREE =250 nM, 2 μM InsP3. Channels were recorded at 0 mV holding 
potential. 
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treatment resulted in a dramatic decrease in the Po of the channel. Reversal of this effect 
by treatment with protein phosphatases and a CaMKII inhibitor is shown (Figures 14A 
& C). These data add support to the hypothesis that it is the CaMKII-mediated 
phosphorylation of the channel that is responsible for the decrease in Po seen upon 
CaMKII addition.  In addition to implicating direct phosphorylation of the InsP3R2 by 
CaMKII as the mechanism of regulation, these results also show that the site of CaMKII-
dependent phosphorylation resides on the large cytoplasmic portion of the InsP3R2.  
Since CaMKII added to the cis side of the bilayer could produce the inhibitory effect on 
the InsP3R2, it can be concluded that the phosphorylation site for CaMKII is exposed to 
the cis solution when a channel correctly orients itself in the lipid bilayer.  With InsP3 
present on only the cis side of the bilayer, I know that any channel activity that is 
observed is due to an InsP3R2 that has incorporated with the LBD facing the cis side.  In 
correlation with my previous results shown in Chapter 4, this is where Serine-150 is 
located in the quaternary structure of the tetrameric protein. 
 
2. Serine-150 is a site of CaMKII-dependent modulation of the 
InsP3R2 channel 
In addition to the InsP3R2-S150A non-phosphorylatable mutation used in Figure 
10, the InsP3R2-S150E phosphomimetic mutation was made for use in planar lipid 
bilayer studies by using site-directed mutagenesis to change Serine-150 to a Glutamate 
(S150E).  WT and the two mutant (S150A and S150E) constructs were transiently 
transfected into COS-1 cells for expression of the proteins.  Microsomal fractions from 
the three samples were prepared for use in channel recordings from planar lipid bilayers.  
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In Figure 15A, a sample recording from WT microsomes shows that upon CaMKII 
treatment, the open probability of the channel is significantly decreased.  Conversely, the 
channel trace shown in Figure 15B from InsP3R2-S150A microsomes did not show any 
decrease in open probability when active CaMKII enzyme was added to the bath solution, 
indicating that channel was resistant to the effect of CaMKII-dependent phosphorylation.  
Finally, Figure 15C is a representative channel trace from InsP3R2-S150E microsomes 
showing that this channel protein exhibits a constitutively low open probability thus 
mimicking an InsP3R2 that has been phosphorylated by CaMKII.  This supports the 
hypothesis I proposed earlier that a phosphomimetic mutation of the modulatory CaMKII 
phosphorylation site on the InsP3R2 would create a channel with an open probability 
similar to that of an InsP3R2-WT channel treated with CaMKII.  Indeed this is the case, 
and it also confirms that replacing Ser-150 with a Glutamate did not alter the ability of 
the receptor to form a functional tetrameric channel.  Figure 15D is a summary bar graph 
showing the open probability of the three InsP3R2 channels and the effect CaMKII has on 
each of them. 
 
 
 
 
 
 
 75
+ CaMKII (1500 units) 
 Po 
D. 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
(3) 
S150A     
+  
CaMKII 
S150A S150E 
(3) (3) (4) 
(3) 
WT WT       
+ 
CaMKII 
O 
C 
C 
C 
O 
O 
A. 
B. 
C. 
InsP3R2-S150A (+ 2 μM InsP3) 
+ CaMKII (1500 units) 
20 min 
P0 = 0.57 P0 = 0.58 
10 
pA 1 s 
200 ms 
10 
pA 1 s 
200 ms 
InsP3R2 (+ 2 μM InsP3) 
20 min 
P0 = 0.04 P0 = 0.57 
10 
pA 1 s 
200 ms 
P0 = 0.02 
InsP3R2-S150E (+ 2 μM InsP3) 
Figure 15: Representative single channel recordings of WT, S150A and S150E 
InsP R2s 3
 
(A) For WT-InsP R2 single channels, a channel Po3  of 0.57 was recorded.  To the 
bath solution, 1500 units of active CaMKII enzyme were then added and recording 
continued. This treatment resulted in a decrease in the Po to 0.04 after 20 min. (B) 
For S150A channels, a channel Po of 0.58 was recorded. To the bath solution, 1500 
units of active CaMKII enzyme were then added and recording continued. This 
treatment resulted in no change in the recorded Po of the channel after 20 min.  (C)  
For S150E channels, a channel Po of 0.02 was recorded. A, B & C were taken as 
representative windows having Po’s reflecting the 5 min recordings used for the 
actual determination of Po. Channel openings are shown as upward deflections from 
the zero current level.  (D) Summary bar graphs show CaMKII treatment resulted in 
a dramatic decrease in the Po
 
 of the WT channel. This effect could be inhibited by 
mutation of S150 to Alanine (S150A).  The S150E show a constitutively low Po, 
similar to the WT channel treated with CaMKII.  The conditions for this study were 
220/20 mM CsCH  (cis/trans), [Ca2+SO ]3 3 FREE =250 nM, 2 μM InsP3. Channels were 
recorded at 0 mV holding potential. 
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3. A subconductance state prevails in the InsP3R2-S150E channel 
Further analysis of the InsP3R2-S150E channel revealed the appearance of a 
subconductance state (Figure 16).  This open state was ~2.5-3 pA in amplitude, which is 
approximately half of the normal opening current amplitude seen in the WT channel.  
The traces in Figure 16 show this subconductance state.  The records are expanded (see 
scale bars) to illustrate the small open state seen in the InsP3R2-S150E channels.   The 
asterisk denotes a full opening (~5.0 pA) interspersed within the subconductance 
openings.  Upon further review of the InsP3R2-WT channels recorded from microsomes 
from COS-1 cells transfectd with the InsP3R2-WT construct, it was revealed that this 
subconductance state is also observed in these traces (see Figure 17), with a similar 
incidence of this state compared to the main opening.  In Figure 17, amplitude 
histograms of an InsP3R2-WT channel (A) and an InsP3R2-S150E (B) channel are shown 
for comparison.  The histograms represent small portion of the two channel’s full traces 
in order to illustrate the presence of the subconductance state in the WT channel as well 
as the S150E.  No statistical analysis of this is provided because of a lack of a sufficient 
number of channels due to the difficulty obtaining these traces for S150E channels. 
 
4. High cytoplasmic [Ca2+]FREE activation of the InsP3R2-S150E 
channel 
In an effort to try and “override” the low open probability of the InsP3R2-S150E 
with a large [InsP3], an interesting characteristic of the InsP3R2-S150E was found. As 
shown in Figure 18A, an InsP3R2-S150E channel in the presence of 800 nM [Ca2+]FREE 
and 8 µM InsP3 exhibited high activity not characteristic of this channel.  The 800 nM 
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 Figure 16: InsP R2-S150E channel shows a subconductance state 3
  Representative single channel traces of InsP3
 
 
 
R2-S150E channels. The sample records 
shown are 375 ms in duration and were taken as representative windows of the 
complete trace.  Channel openings are shown as upward deflections from the zero 
current level.  Note the decreased amplitude scale bar to illustrate the decreased 
amplitude of this observed subconductance state.  A full opening is indicated (*). The 
conditions for this study were 220/20 mM CsCH 2+ (cis/trans), [CaSO ]3 3 FREE =250 nM, 
2 μM InsP3. Channels were recorded at 0 mV holding potential. 
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 Figure 17:  Amplitude histograms of InsP
 
 
 
 
3R2-WT and InsP R2-S150E channels 3
 
(A) Amplitude histogram of a portion of an InsP3R2-WT channel shows the presence 
of an approximately 2.5-3 pA subconductance state along with the full open state (~5 
pA).  (B) The InsP3R2-S150E channel shows a small population of opening events at 
the 2.5 pA level, with the majority of events at the 0 pA level. Red traces are Gaussian 
fits of the histograms. 
 79
[Ca2+]FREE was present in order to increase the molarity of the cis chamber and promote 
fusion of the microsomes with the lipid bilayer.  Recording of this channel was begun 
(Figure 18A) and after a few minutes, 1 mM EGTA was added to bring the [Ca2+]FREE to 
the normal recording value of 250 nM.  Within one minute of this addition, a change in 
the current amplitudes of the channel could be observed (Figure 18B).  The channel 
seemed to shift to a subconductance state of 2.5 pA with more closings present than prior 
to EGTA addition.  This is illustrated in the amplitude histogram of this recording shown 
in Figure 19A & B.  After 5 min post-EGTA addition, the channel recording resembled 
that of a typical InsP3R2-S150E channel (Figure 18C and 19C).  The channel was in a 
state of very low activity and even the presence of the increased [InsP3] did not have an 
effect on the channel’s activity.  In the presence of 800 nM Ca, the S150E channel was 
highly active with the stoichiometry of main conductance state and the subconductance 
approximately 1:0.6.  This is similar to the observed distribution for WT channels.  
Addition of EGTA resulted in an immediate closure of the main open state, with the 
subconductance openings remaining; however, this open state was also reduced after 5 
min at 250 nM Ca2+.  These results may also suggest that the Ca2+ sensitivity of the 
S150E mutants are altered. 
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Figure 18: InsP R2-S150E channel shows increased activity in high [Ca2+]3 FREE
 
Representative single channel traces of WT, S150A, and S150E InsP3R2 in various 
[Ca2+]FREE. (A) Representative trace of an InsP3R2-S150E channel in 800 nM 
[Ca2+]FREE.  The same channel is shown 1 min (B) and 5 min (C) after the addition of 1 
mM EGTA to adjust [Ca2+]FREE to 250 nM.  With the decrease of the [Ca2+]FREE from 
800 nM to 250 nM, the channels appears to transition from a state with relatively few 
closings (0 pA) and many full (5 pA) and subconductance (2.5 pA) openings (A), to an 
intermediate state with more closings and a prevalence of the subconductance state 
(B), and eventually to a state where the channel is essentially inactive (C).  The 
conditions for the single channel studies were 220/20 mM CsCH SO3 3 (cis/trans) and 8 
μM InsP3. Open (O), closed (C), and substate (S) shown. 
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 Figure 19: Amplitude histograms of an InsP3
 
R2-S150E channel in response to 
changes in [Ca2+]FREE
 
2+
 
(A) Amplitude histogram of an InsP R2-S150E channel in 800 nM [Ca ]3 FREE. 
 
 The 
same channel 1 min (B) and 5 min (C) after the addition of 1 mM EGTA to adjust 
[Ca2+
 
]FREE to 250 nM.  With the decrease of the nM [Ca2+]FREE from 800 nM to 250 
nM, the channels appears to transition from a state with relatively few closings (0 
pA) and many full (5 pA) and subconductance (2.5 pA) openings (A), to an 
intermediate state with more closings and a prevalence of the subconductance state 
(B), and eventually to a state where the channel is essentially inactive (C).  A, B and 
C correspond to the same traces in Figure 18. Red traces are Gaussian fits of 
histograms. 
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C. DISCUSSION 
 1. Summary of Results 
InsP3R2s are intracellular Ca2+-release channels that play a role in the regulation 
of Ca2+-signaling in the cardiac myocyte.  Their role in the regulation of ET-1 induced 
positive inotropy in both atrial and ventricular myocytes has been recently well-
characterized, along with their part in a nuclear signal transduction cascade involving 
CaMKII-mediated activation of gene expression.  Thus, CaMKII-dependent 
phosphorylation of the InsP3R2 is an important method of physiological regulation of the 
channel in a cellular environment.  This is the first report of the exact site of CaMKII-
mediated phosphorylation of the InsP3R2 along with the functional effects of this post-
translational modification on the channel’s activity.  In addition, important function 
implications into the mechanism of the inhibition of activity of the channel can be 
conjectured from my results of single channel analysis of the InsP3R2-S150E channel.  
The data presented above clearly show that S150E of the InsP3R2 is the site of 
modulation of the channel’s activity by CaMKII-dependent phosphorylation.  
Phosphorylation leads to inhibition of the InsP3R2 and this functional effect can be 
inhibited by mutation of S150 to Alanine in the InsP3R2.  Furthermore, a 
phosphomimetic InsP3R2 channel (InsP3R2-S150) exhibits a constitutively low open 
probability much like that seen with a WT channel phosphorylated by CaMKII.  My data 
also indicate that this phosphorylation event can actually shift the Ca2+ activation curve 
(Figure 2B) of the InsP3R2 dramatically to higher [Ca2+]FREE (~800 nM).  
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2. Functional Consequences of CaMKII-mediated phosphorylation of 
the InsP3R2 
Type 2 InsP3R-mediated signals have a sigmoidal Ca2+-dependence meaning 
termination of this signal is not intrinsically controlled by a Ca2+-dependent inactivation 
mechanism.  Of significance in cardiac tissues where type 2 receptors are present, this 
sigmodial Ca2+-dependence makes the InsP3R2 resistant to the RyR-mediated Ca2+ 
signals driving the cardiac contractile cycle and allows InsP3-dependent intracellular 
signaling cascades to operate independent of the global Ca2+ fluxes associated with 
contraction.  Potential mechanisms of termination of the InsP3R2 response include total 
depletion of the Ca2+ store, removal of the InsP3 signal, or regulation through a 
modulatory protein (i.e. CaM, CaMKII, CaBP, PKA, etc.).  My data show that CaMKII 
can directly phosphorylate the InsP3R2 at Serine 150, and phosphorylation results in the 
inhibition of channel activity and thus termination of InsP3-mediated SR and nuclear Ca2+ 
release (Figure 14A and Figure 15A).  
The InsP3R2 is localized to both the SR and the nuclear envelope in cardiac 
myocytes (Mackenzie et al., 2002; Bare et al., 2005).  CaMKII-mediated phosphorylation 
of InsP3R2 most likely has different physiological effects based on which population of 
receptors is being phosphorylated.  Data show that knock-out of InsP3R2 in mouse 
myocytes abolished the positive inotropic and arrhythmogenic effects of ET-1 in cardiac 
myocytes (Li et al., 2005) and the ET-1 induced HDAC5 nuclear translocation in 
ventricular myocytes (Wu et al., 2006).  This HDAC5 pathway seems to be isolated from 
the beat-to-beat global fluctuations in [Ca2+]i, creating an elegant system that is 
dependent on very local control of [Ca2+] around the pore of the InsP3R.  The hypothesis 
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is that InsP3 can activate nuclear envelope InsP3Rs, releasing Ca2+ into the nucleoplasm 
with very high concentrations of Ca2+ immediately adjacent to the mouth of the InsP3R 
activating CaMKII, which can phosphorylate HDAC5 and cause its translocation out of 
the nucleus (Wu et al., 2006).  Furthermore, it has been proposed that the activated 
CaMKII can feedback inhibit the InsP3R to close the channel and terminate the InsP3R-
mediated release of Ca2+ from the nuclear envelope into the nucleoplasm.  My results 
presented here strengthen this hypothesis and show that CaMKII feedback 
phosphorylates the InsP3R2 at Serine 150, and this phosphorylation results in a decrease 
of the channel’s open probability.  This is an important part of signaling pathway leading 
to hypertrophy and heart failure.  In HF this could have a potentiating effect as a 
feedback loop as the increased gene expression through InsP3R2-dependent Ca2+-
activation of CaMKII leads to increased InsP3R2 levels and thus further Ca2+ in the 
nucleus thus reinforcing this pathway. 
The next question is what functional effects CaMKII-dependent phosphorylation 
of SR-localized InsP3R2s has in the cellular context of the cardiac myocyte.  InsP3R2s 
co-localize with RyRs in both atrial and ventricular cells and can modulate the activity of 
the RyR (Mackenzie et al., 2002; Zima and Blatter, 2004; Domeier et al., 2007).  IICR 
can potentiate CICR from RyRs leading to enhanced systolic SR Ca2+ release and 
positive inotropy.  One possibility is that CaMKII-mediated phosphorylation of this 
population of InsP3R2s would restrain or limit the potentiating effects of IICR on CICR.  
This could serve as a mechanism to prevent the arrhythmogenic effects that occur upon 
ET-1 application.  In addition, it could have a significant effect on diastolic SR Ca2+ leak 
by decreasing spontaneous openings of the RyR due to decreased propensity for CICR.  
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This effect of phosphorylation can also be anti-arrhymogenic during diastole preventing 
activation of the electrogenic Na+/Ca2+ exchanger (NCX) and generation of DADs.  In 
addition to modulation of CICR from RyRs to prevent arrhythmias, phosphorylation of 
the InsP3R2 by CaMKII in the cytosol could provide a mechanism to prevent arrhythmias 
during β-adrenergic and ET-1 stimulation.  In instances of ET-1 stimulation, InsP3 levels 
in the cytosol will be significantly higher due to activation of the PLC-InsP3 pathway.  
This would prime the InsP3R2 to become more sensitive to Ca2+ activation and more 
likely to cause spontaneous arrhythmogenic SR Ca2+-release events.  Due to the Ca2+-
sensitivity property of InsP3R2s, the increased Ca2+ (along with InsP3) in this 
microdomain could cause spontaneous activation of InsP3R2s, which in turn activate RyR 
Ca2+-release causing DADs or pro-arrhythmic action potential aberrations.  The CaMKII 
localized in this microdomain would be activated by the increased [Ca2+] and 
phosphorylate and inhibit the InsP3R2.  Therefore, due to the relatively low expression 
levels of InsP3R2s compared to RyRs (Moschella and Marks, 1993), SR Ca2+ release 
from InsP3R2s alone doesn’t affect the beat-to-beat global Ca2+ transient during action 
potential stimulation in the cell.  However, it can influence RyR-mediated SR Ca2+ 
release which does affect the global SR Ca2+ release.  Thus, it seems the effect of 
CaMKII-mediated phosphorylation of the SR-localized InsP3R2s would have an indirect 
effect on global SR Ca2+ relese through modulation of the RyR.   
Atrial myocytes from the InsP3R2-KO mouse exhibited decreased spark 
frequency when treated with ET-1 compared to WT treated with ET-1 (Li et al., 2005).  
This is presumably due to the loss of the potentiating effect IICR has on the RyR-
mediated SR Ca2+ release.  In contrast, in cardiac myocytes from the InsP3R2-KO mouse 
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the β-adrenergic agonist isoproterenol still was able to increase spark frequency and Ca2+ 
transient amplitude, showing that the transgenic animal was able to maintain an inotropic 
reserve.  Furthermore, this indicates that β-adrenergic modulation of SR Ca2+ release 
works through pathways other than the PLC-InsP3 pathway (Li et al., 2005).  Therefore, I 
propose that phosphorylation of the InsP3R2 by CaMKII may have a protective effect 
during stimulation of the PLC- InsP3 pathway in cardiac myocytes in preventing or 
reducing the arrhythmogenic effects of ET-1. 
In heart failure, the InsP3R2 is upregulated (Figure 3; see also Go et al., 1995).  
Functionally, the majority of experimental evidence indicates that in cardiac myocytes 
the modest inotropic effect of the InsP3R2s also comes with the considerable ability to 
disrupt ECC at normal SR Ca2+ load (Mackenzie et al., 2002).  Despite this, the 
upregulation of the InsP3R2 seen in HF may be an attempt to preserve and enhance the 
inotropic response of ET-1 in this condition.  Aside from this positive effect, I propose 
another possibility for the physiological significance of the increased density of InsP3R2s 
in the pathological condition of HF.  It is that the InsP3R2s have a role in apoptosis of 
myocytes seen in cases of HF.  It was shown that CaMKII deletion in myocytes 
prevented apoptosis (Ling et al., 2009).  Could InsP3R2-mediated Ca2+ release be the link 
between CaMKII and apoptosis in that the deletion of CaMKII prevents it from activation 
the expression of genes, specifically the upregulation of the InsP3R2?  The expression of 
many other proteins can be modulated by CaMKII-mediated phosphorylation of nuclear 
proteins that control transcription (Ling et al., 2009), so perhaps the increased InsP3R2 
protein level is one of many factors contributing the apoptosis of cardiac myocytes seen 
in HF.  It has been shown that InsP3R-mediated Ca2+ release plays a role in apoptosis, and 
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the InsP3Rs localize in close proximity to the mitochondria (Rizzuto et al., 1998; Hanson 
et al., 2008; Rong et al., 2008).  In rat ventricular myocytes, it has also been shown that 
Ca2+ signals can be passed between the two organelles (Sharma et al., 2000).  The 
hypothesis that IICR can potentiate CICR here from RyRs is also a possibility, as 
functional RyRs were shown at SR/mitochondrial junctions in rat ventricular myocytes 
(Lukyanenko et al., 2007).  Perhaps the InsP3R protein density is increased in areas of 
SR/mitochondrial junctions to create a signaling domain in which Ca2+ release from 
InsP3Rs can cause CICR from RyRs or independently be sensed by mitochondria and 
induce the apoptotic pathway contributing to the pathology of HF. 
In addition to the increased InsP3R2 protein levels, the levels of the RyR are 
decreased in HF. Does the increased InsP3R2 protein level contribute to 
arrhythmogenesis and the mishandling of Ca2+ regulation also seen in HF, or do the 
InsP3R2s create an environment where this increased expression in the SR can help 
potentiate CICR from the decreased population of RyRs?  As shown in Figure 3, the 
nuclear envelope InsP3R2s are clearly up-regulated in the HF rabbit myocytes, but areas 
of staining extending from the nuclear envelope are also seen in HF.  This could be a 
dense population of InsP3R2’s that co-localize with RyRs in myocytes and contribute to 
the propagation of the Ca2+ wave for contraction.  The might represent a compensatory 
mechanism during heart failure, thus allowing greater facilitation of CICR by the calcium 
released through the InsP3R2.  Despite the fact that the InsP3R2 is up-regulated and the 
RyR is down-regulated in HF, I do not support a notion that the InsP3R2s take the place 
of the RyR as the main Ca2+ release channel of the cardiac myocyte.  We have created 
antibodies to the phosphorylated and non-phosphorylated forms of Serine-150 of the rat 
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InsP3R2 to detect the total InsP3R2 and the CaMKII phosphorylated InsP3R2 in WT and 
HF myocytes.  These experiments will give us further insights into CaMKII-mediated 
regulation of the InsP3R2 during normal and pathological conditions. 
One final possibility for the physiological significance of CaMKII-mediated 
phosphorylation of the InsP3R2, is that phosphorylation “tunes” the InsP3R2 to be 
responsive in conditions of high [Ca2+]i.  The results in Figures 18 and 19 are 
preliminary (n=1), but it is worth speculating on their potential.  The phosphomimetic 
InsP3R2 channel could be activated by increased cytosolic [Ca2+] (~800 nM) and high 
[InsP3] (8 µM).  It is unclear what effect [InsP3] has on this activation, but the [Ca2+] may 
be more critical since the channel activity could be abolished by returning the [Ca2+] to 
normal.  Thus, it is possible that CaMKII-mediated phosphorylation of the InsP3R2 leads 
to channel inhibition by shifting its Ca2+-sensitivity to higher [Ca2+], which causes the 
channel to  become responsive only during periods of increased [Ca2+]i potentially 
independent of increased [IP3].  Many possibilities on the physiological significance of 
this property can be postulated in various instances of increased [Ca2+]i in the myocyte.  
For example, this could allow the positive inotropic effects of InsP3R2 activation to 
persist in the face of high [Ca2+]i due to increased heart rates.  Another example is during 
cases of HF and potentially takes place on a similar or shorter timescale to the example 
above.  Perhaps the high [Ca2+]i during systole creates an environment that activates the 
InsP3R2 and allows it to continue having the positive inotropic effect seen in normal 
myocytes that would be beneficial to sustaining heart function during HF.  On the other 
hand, there is also the possibility that this would cause even more pronounced 
arrhythmogenic effects based on when the InsP3R2 actually activates during the Ca2+ 
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cycle.  Concerted activation with the RyR may help to prolong or potentially increase the 
Ca2+ transient amplitude and increase the force of contraction, whereas activation of the 
InsP3R2s at other points during Ca2+ transient could cause EADs or DADs.  The question 
remains whether this concerted activation would help increase the Ca2+ transient 
amplitude in the condition of decreased SR Ca2+ content as seen in HF.  Furthermore, 
given the timescale necessary to experimentally produce the CaMKII mediated effects on 
the InsP3R2 in vitro (minutes to tens of minutes), it is also unclear if the above examples 
would still be viable possibilities of the physiological significance of CaMKII-mediated 
phosphorylation of the InsP3R2.  However, these hypotheses have yet to be tested in a 
cellular environment.  Considering the data that implicate CaMKII in the induction and 
progression of hypertrophy and heart failure, it seems unlikely that it would have a 
compensatory effect in HF.  However, the results in Figures 18 and 19 indicate that it 
could be a possibility.  Another important point in the hypothetical examples discussed 
above is what Ca2+ signal is activating the CaMKII?  Is it the increased [Ca2+] in the 
microdomain of the InsP3R2/CaMKII signaling complex as has been demonstrated for 
the nuclear cascade, or is it the stimulation of the β–adrenergic pathway of the myocyte?  
A complete understanding of this complex regulatory pathway and its effects on the 
myocyte as a whole requires a comprehensive study of the InsP3R2, RyR, CaMKII, the 
separate and overlapping effects of the ET-1 and β–adrenergic pathway stimulation, and 
the various changes in [Ca2+]i and SR Ca2+ to see the larger picture of this regulation in 
WT and HF myocytes. 
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3. Mechanism of Inhibition 
IP3 binds to a distinct region of the IP3R located at the amino terminal of each 
subunit known as the ligand binding domain (LBD).  This region can be divided into the 
IP3-binding core (IBC) and a second region that reduces affinity of binding core for IP3 
and thus has been called the suppressor domain (SD). The suppressor domain is required 
for channel gating as it was shown that removal of suppressor domain increased affinity 
for IP3 but did not form a functional channel (Uchida et al., 2003). The crystal structures 
for the IBC (Bosanac, 2002) and the SD (Bosanac, 2005) have both been solved.  Based 
on the location of S150/T150 in exposed beta strand 7, it is in close proximity to regions 
of potential interaction between the IBC and SD of the LBD (Bosanac et al., 2005).  
Therefore, I postulate that modification of this site could sterically hinder IP3 from 
binding to the IBC or that phosphorylation disrupts the interaction of the SD and IBC 
thus preventing ligand induced activation. Figure 20 is a surface electrostatic potential 
representation of the SD with and without the phosphomimetic mutation.  This 
representation shows a large change in the charged regions of the surface of the SD upon 
replacement of Serine with Glutamate at residue 150 to mimic a phosphorylated Serine-
150.  Specifically, a decrease in the positive charge pocket exposed on the surface of the 
SD is shown.  This change in the surface electrostatic potential could have a few effects 
on the function and structure of the LBD.  One, is that the increases in negative potential 
repel the negatively charged IP3, thus decreasing the affinity of the LBD for IP3.  A 
second possibility is that the change in surface electrostatic potential causes a change in 
the tertiary structure of the LBD.  This could be either a stronger or weaker  
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A. 
WT 
B. 
S150E 
 
 Figure 20: Surface electrostatic potential representations of the InsP3
 
R2 
suppressor domain 
 
R2-WT (A) and the InsP
 
Surface charge representations of the InsP3 3
 
R2-S150E (B) 
suppressor domains.  Addition of the S150E mutation in (B) causes the negatively 
charged pocket in near the center of the representation to become larger and more 
intense.  It also causes a decrease in the positively charged pocket located below it in 
the representation.  A scale bar is shown below the figures corresponding to the 
intensity of electrostatic potential and is in units kT/e.  Red represents negative 
electrostatic potential, while blue is positive electrostatic potential.  This figure was 
generated with the molecular viewer program Pymol. 
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intramolecular interaction based on what regions and charges interact, and it could be due 
to the greatly increased pocket of negative electrostatic potential or the moderate decrease 
the closely localized positive pocket.  Either way, this change in surface electrostatic 
potential of the LBD with the addition of a negatively charged residue could have drastic 
structural effects of the LBD and also functional effects on the LBD’s ability to translate 
IP3 binding into channel opening.  Despite the experimental results and the insights from 
molecular modeling, the question still remains whether this contributes to a decrease in 
the affinity of the LBD for InsP3 or if it interferes with the intramolecular interaction of 
the SD/IBC necessary for proper channel function; however, this has been the focus of 
my continual research.   
 In support of this hypothesis that phosphorylation disrupts the interaction of the 
SD and IBC, analysis of interactions of the SD and IBC of IP3R1 established that either  
or both of E153 and A154 from loop 7 interact directly with the IBC.  These sites are 
extremely close to the CaMKII phosphorylation site of the InsP3R2 at S150.  
Furthermore, a series of partial agonists of the IP3R were synthesized and used to define 
key steps in IP3R activation (Rossi et al., 2009).  The partial agonists opened the channel 
to the same open state (current amplitude, single channel conductance, and mean channel 
open time all the same for agonists and partial agonists); however, the partial agonists 
opened the InsP3R less effectively.  Utilizing these partial agonists and their ΔG for 
binding, it was shown that the major conformation changes evoked by IP3 occur within 
the N-terminus and pass to the pore entirely via the suppressor domain (Rossi et al., 
2009), most likely through its interaction with the S4-S5 linker (Schug and Joseph, 2006).  
This explanation could also account for the prevalence of the subconductance state 
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observed as the InsP3R2-S150E channel is inhibited by decreasing the [Ca2+]FREE (Figure 
18 and 19).  Perhaps the SD/IBC interaction is perturbed in such a way by 
phosphorylation of the Serine-150 residue that partial gating of the channel results, thus 
producing the prevalence of the 2.5 pA state observed (Figures 18B and 19B).  This 
subconductance state was also observed in the InsP3R2-WT channels; however, it is 
possible that this smaller open state must be reached before the full open state (5 pA) is 
reached, and CaMKII-mediated phosphorylation prevents transition from the partial to 
full open state of the InsP3R2 (Figure 18B and 19B).  The energy of InsP3 binding to the 
IBC cannot be fully transferred into gating of the channel due to the aberrant interaction 
of the SD and the IBC, thus producing the subconductance state observed in planar lipid 
bilayers with the InsP3R2-S150E channel.  The additional Ca2+ necessary to produce 
channel openings (Figure 18A and 19A) may perhaps screen this negative charge 
present due to the phosphorylation of Serine-150 (see Figure 20) and restore the proper 
interaction of the SD and IBC.  This would be an explanation as to why I see high 
channel activity in the presence of high [Ca2+]FREE (Figures 18A and 19A).  Building on 
the results of Figures 18 and 19, it would be interesting to see what effect any cation has 
on the reversal of CaMKII-mediation inhibition of the InsP3R2.  Based on my proposal 
above that the Ca2+ serves to screen the negative charge of a phosphorylated Serine-150, 
any positively charged ion could serve this role of screening the negative charge that 
results from CaMKII-mediated phosphorylation.  If this was the case, perhaps it would be 
observed experimentally that divalents such as Ca2+ or Mg2+ are more efficient than 
monovalents at screening of the negative charge and causing reversal of the inhibition.  
Furthermore, the negatively charged Glutamate residue at position 2100 has already been 
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implicated in the Ca2+ sensitivity of the InsP3Rs (Chapter 1.A.2, Miyakawa et al., 2001), 
showing that Ca2+ attraction to negatively charged regions of the InsP3R can have an 
effect on the function of the channel.  In summary, I propose a mechanism for inhibition 
of channel gating by which CaMKII-mediated phosphorylation of S150 causes a 
disruption of the suppressor domain-binding core interaction, thus uncoupling ligand 
binding from channel opening.   
The FIRE-2 biosensor is an excellent tool with which to test part of this 
hypothesis.  Like FIRE-1, the FIRE-2 biosensor is an InsP3-sensor that responds to 
increasing [InsP3] by exhibiting an increase in the FRET between the CFP and YFP 
proteins that flank the LBD of the InsP3R2.  Essentially, the change in FRET measured 
can be plotted along with the [InsP3] at which the measurement was taken to create a 
dose-response curve of the biosensor for InsP3.  From this, I can determine the EC50 for 
InsP3 and FRETmax for the biosensor, which will give insights into the affinity of the 
sensor for InsP3 (EC50) and how the S150E phosphomimetic mutation may affect the 
conformation of the sensor (FRETmax).  Thus, I have a tool with which to measure these 
properties for FIRE-2 and the phosphomimetic mutant FIRE-2-S150E.  Furthermore, 
FIRE-2 is critical for this study in that it separates InsP3 binding from ligand-induced 
gating of the channel leading to InsP3-induced Ca2+ release typically used for functional 
studies.  This allows me to separate ligand binding from channel gating and specifically 
study the effect the S150E mutation has on the LBD’s affinity for InsP3.   
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  4. The interaction of CaMKII and InsP3R2 
Finally, the interaction between CaMKII and the InsP3R2 may be affected by 
phosphorylation.  It has been shown that CaMKII can interact with the first 1078 amino 
acids of the InsP3R2 in vitro.  Furthermore, an in vivo interaction was also shown 
between CaMKII and the InsP3R2 in rat myocyte nuclei (Bare et al., 2005).  My data 
show that the region of interaction also contains the site of CaMKII-mediated 
phosphorylation on the InsP3R2.  The effect of CaMKII-mediated phosphorylation of the 
InsP3R2 on the interaction of these two proteins, however, has yet to be demonstrated.  
Perhaps phosphorylation allows the kinase to dissociate from the receptor and act on 
downstream targets.  It would be worthwhile to determine what proteins and factors also 
contribute to this interaction in the cell.  Previously, the InsP3R1, PKA, PP1 and PP2A 
have been shown to form a macromolecular complex in the rat brain (DeSouza et al., 
2002).  Does a similar complex exist in the heart for CaMKII and the InsP3R2?  There is 
a CaM binding site nearby Serine-150, just upstream at amino acids 106-128 of the type 1 
that is conserved in the type 2 InsP3R receptor (Sienaert et al., 2002).  This strengthens 
the hypothesis that the InsP3R2 and CaMKII form a macromolecular complex with CaM 
potentially serving as the link between the two proteins.  CaM positions the CaMKII 
spatially to activate during the Ca2+ signals from the InsP3R and then phosphorylate the 
nearby Serine-150 to inhibit the activity of the InsP3R2.  This also implicates CaM as a 
Ca2+-sensor for the InsP3R2, fulfilling the role through activation of CaMII and its 
subsequent phosphorylation and inhibition of the channel.  A second candidate for the 
interaction of CaMKII with InsP3R2 is αKAP.  αKAP may spatially position CaMKII to 
modulate the InsP3R as it does with CaMKII, phospholamban and SERCA2a (Singh et 
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al., 2009).  Through mutagenesis, it was shown that SERCA2a and CaMKII each interact 
with distinct regions of αKAP, thus forming a complex of proteins that can regulate each 
other’s activity.  It is through this interaction that αKAP spatially positions CaMKII to 
phosphorylate PLB and modulate its interaction and regulation of SERCA2a (Singh et 
al., 2009).  Perhaps αKAP plays a similar role in the regulation of the InsP3R2 by 
CaMKII by forming a similar complex of proteins in the SR/ER or nuclear envelope. 
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CHAPTER SIX 
SUMMARY 
 
One mechanism in which calcium is mobilized from intracellular stores is via the 
activation of inositol 1,4,5-trisphosphate receptors (InsP3Rs) by the second messenger, 
inositol 1,4,5-trisphosphate (InsP3).  InsP3Rs are a family of highly conserved 
intracellular Ca2+ release channels.  InsP3Rs can be of three isoforms (type 1-3), and are 
structurally very similar to each other (Mignery et al., 1992) with multiple isoforms often 
expressed within a single cell.  Activation of InsP3Rs leads to release of calcium into the 
cytoplasm of the cell, where it can activate a multitude of signal transduction cascades 
and a variety of local and global cellular events.  One such enzyme activated by a rise in 
intracellular [Ca2+] is Ca2+-calmodulin-dependent protein kinase II (CaMKII).  CaMKII is 
a multifunctional Serine/Threonine protein kinase involved in many signaling pathways 
in various cell types.  Recent results from our lab have shown that InsP3Rs in the heart 
(InsP3R2) are primarily targeted to the nuclear envelope in ventricular myocytes.  Here it 
forms a macromolecular complex with one of the cardiac isoforms of CaMKII, 
CaMKIIδB.  Upon stimulation of InsP3 production, Ca2+ released through the InsP3R2 
activates CaMKIIδB, allowing it to act on downstream targets, such as HDAC4 & 5 
(Little et al., 2007; Wu et al., 2006).  Additionally, CaMKII feedback modulates InsP3R2 
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function by direct phosphorylation and results in a significant decrease in the channel’s 
open probability (Bare et al., 2005; Figure 14).  The results of this study and others 
suggest that the activity of InsP3Rs can be inhibited by CaMKII-mediated 
phosphorylation.  Furthermore, the N-terminal 1078 amino acids of the InsP3R2 have 
been shown to interact with, as well as be phosphorylated by CaMKII (Bare et al., 2005).  
However, it has not yet been established what amino acid of InsP3Rs is phosphorylated.  
The goal of this project was to determine what amino acid residue(s) of the InsP3R2 is 
phosphorylated by CaMKII and, upon phosphorylation, has an effect on the properties of 
the channel.  This will give us a better functional understanding of how InsP3R and 
CaMKII regulate each other and perhaps insight into the mechanism of inhibition.   
To test the hypothesis that activated CaMKII feedback modulates the InsP3R2 via 
direct phosphorylation and disruption of those sites can abolish phosphorylation and the 
resulting functional consequences, I proposed three Specific Aims by which to 
accomplish this objective.  In Aim 1, I used exogenously expressed fragments that I made 
of the InsP3R2 to show that CaMKII can phosphorylate the InsP3R2 at Serine-150. 
In Aim 2, I used site-directed mutagenesis to prevent Serine-150 phosphorylation 
by mutation to Alanine.  Mutation of Serine-150 to Alanine successfully abolished 
CaMKII-dependent phosphorylation of two different InsP3R2 sub-fragments that were 
tested.  In addition, this mutation was made in the full-length rat InsP3R2, and it was able 
to prevent CaMKII-mediated phosphorylation of the recombinant full-length InsP3R2 in 
vitro.  These results unambiguously identify Serine-150 of the rat InsP3R2 as the CaMKII 
phosphorylation site.  Furthermore, these results suggest that this is the only CaMKII-
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dependent phosphorylation site present on the InsP3R2 since mutagenesis of this site 
completely abolished CaMKII-mediation phosphorylation.   
Finally in Aim 3, I confirmed that Serine-150 of the InsP3R2 is the modulatory 
site of CaMKII-dependent phosphorylation.  Abolishment of this site prevented the 
CaMKII-mediated effects on the InsP3R2 in planar lipid bilayers.  Treatment of a non-
phosphorylatable (S150A) InsP3R2 protein with CaMKII had no effect on the open 
probability of the channel, while a phosphomimetic (S150E) channel protein displayed a 
constitutively low open probability mimicking a CaMKII phosphorylated InsP3R2.  
Furthermore, the phosphomimetic mutation also showed some interesting features that 
may be physiologically relevant and contribute to elucidating the mechanism of CaMKII-
mediated regulation of the InsP3R2. 
The completion of my Specific Aims and the successful testing of my hypothesis 
has provided further avenues for study.  We have created antibodies against 
phosphorylated and non-phosphorylated Serine-150 in the InsP3R2 that will be useful in 
determining the ratios of phosphorylated to non-phosphorylated InsP3R2 in tissues.  Of 
particular interest would be the amounts of phosphorylated and total InsP3R2 in HF 
myocytes, where the InsP3R2 has been shown to be upregulated.  Perhaps 
immunostaining with these antibodies may even identify specific populations of InsP3R2 
within the myocyte that are phosphorylated.  Furthermore, testing the InsP3R2-WT and 
InsP3R2-S150E Ca2+-release abilities in a cellular environment in response to InsP3 or an 
agonist that activates the PLC- InsP3 pathway would also be excellent supporting data to 
the in vitro planar lipid bilayer results I present here.   
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In addition to this first look at the single channel properties of the InsP3R2-S150E 
protein shown here, an in-depth characterization of this channel and its properties may 
provide further insights to exactly what physiological effect CaMKII-mediated 
phosphorylation of the InsP3R2 has in the healthy and diseased heart. 
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